Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8561601351895869,2.363829532318053,0.0,0.0,0.0,8/22,2.58%,PTGDS;ALDH1A2;ADH7;ADH4;ABCA4;RBP1;CYP26B1;CRABP2
prerank,cadherin binding (GO:0045296),-0.47530879075081334,-2.2044584916189573,0.0,0.001016017962194097,0.001,115/315,15.20%,PTPRM;DOCK9;SPTBN1;COBLL1;PTPRB;FMNL2;STXBP6;CDH11;ABI1;AHNAK;PDLIM5;MRTFB;BMPR2;DAB2IP;MYO1B;CALD1;ESYT2;BSG;ITGA6;VCL;TJP1;LRRFIP1;CLINT1;FXYD5;ACVR1;NOTCH3;PROM1;WASF2;YWHAE;MYH9;CDH13;IQGAP1;EGFR;CDH1;MACF1;PTPRJ;TMPO;TAGLN2;KDR;CAST;F11R;CTNNA1;YWHAB;EIF3E;PHLDB2;SERBP1;FLNA;CHMP2B;ITGB1;MB21D2;TJP2;PAK2;NUMB;PPFIBP1;RACK1;SNX1;EEF2;ANXA1;NCK1;CHMP4B;CLIC1;TRIM25;SPTAN1;EPN2;ALDOA;TRPC4;APC;SCYL1;SWAP70;KTN1;STK24;CNN2;RPL29;RPL7A;RPS26;LDHA;GAPVD1;SRC;TMOD3;VASN;PTPN1;RPL6;PPP1CA;EPS8L2;S100A11;PSMB6;CD2AP;YWHAZ;CTNNA3;FASN;PARVA;LRRC59;RPL24;PRDX6;CAPG;TES;LIMA1;FNBP1L;EHD4;ARHGAP1;PFN1;STK38;RPL34;SHTN1;IST1;TBC1D10A;GOLGA3;CIP2A;RAB11B;CDH2;RPL14;SNX2;CBL;VAPB;CEMIP2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.8471403493094762,-2.094502819353329,0.0,0.006096107773164583,0.008,6/12,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE2A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8733653580875949,2.0465134605379953,0.0,0.02317741085921292,0.038,3/10,0.48%,SLC6A13;SLC6A1;SLC6A12
prerank,amino acid:sodium symporter activity (GO:0005283),0.8204400407396812,1.9186912724423915,0.004273504273504274,0.12722919152504114,0.268,4/11,3.99%,SLC6A13;SLC6A1;SLC6A12;SLC38A1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.706644865860345,-1.9067186395092701,0.0,0.066379840196681,0.151,7/17,7.63%,ATP10A;ATP8B1;PITPNC1;ABCA1;PLTP;MTTP;ABCA3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5872932708901362,-1.904940917351311,0.0,0.05207092056244748,0.158,11/34,12.45%,CYTH3;MYO10;MYO1B;ARAP2;PARD3;IQGAP1;ARAP3;ARAP1;ZFYVE16;JPH2;HIP1R
prerank,histone demethylase activity (GO:0032452),0.6546337025231616,1.8951019892551304,0.0019120458891013384,0.1230375321143324,0.339,10/27,11.87%,KDM7A;FBXL19;PHF8;JARID2;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.752150066732033,1.8901377657659266,0.003929273084479371,0.10612295355111957,0.358,7/15,10.60%,ALDH1A2;ADH4;ALDH1L1;ALDH7A1;ALDH1A1;ALDH3B1;ALDH2
prerank,cAMP binding (GO:0030552),-0.7648063201001002,-1.869861298457987,0.004158004158004158,0.0648219459879834,0.237,5/11,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,retinoic acid binding (GO:0001972),0.7412790785797829,1.8130206502082873,0.0020242914979757085,0.225856471777011,0.672,4/12,16.37%,CYP26B1;NR2F2;RXRA;RARA
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.7072058658423853,1.7981529242145127,0.002066115702479339,0.22557467954771965,0.738,11/15,16.66%,HS3ST3A1;HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7696094602628997,1.79528051702069,0.0038240917782026767,0.20317219731905792,0.75,4/11,2.74%,SLC5A3;SLC5A10;SLC23A2;SLC23A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6142389103277875,-1.7653531469193178,0.0021231422505307855,0.19609146670346075,0.634,8/21,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,vinculin binding (GO:0017166),-0.7247787871627132,-1.7624867939087685,0.00398406374501992,0.17315848984250828,0.645,4/11,6.74%,UTRN;CTNNA1;ACTN1;PXN
prerank,AMP binding (GO:0016208),0.74876165458875,1.7615783200585275,0.009416195856873822,0.251828322243363,0.852,5/11,12.43%,PRKAG2;PRKAG3;ACSS2;MPPED2;PYGL
prerank,acid-thiol ligase activity (GO:0016878),0.7107379823500733,1.7449088544568152,0.014112903225806451,0.26609640211981467,0.9,5/13,9.63%,ACSL1;ACSM2A;ACSM2B;AASDH;ACSS2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.7126364161396158,1.7390197854585405,0.014056224899598393,0.2553549946887365,0.908,6/12,19.45%,KDM7A;PHF8;PHF2;KDM4A;KDM1A;KDM3B
prerank,ligand-gated ion channel activity (GO:0015276),0.5738384005676714,1.7327250295069774,0.011695906432748537,0.2480476098337042,0.919,8/30,8.71%,ANXA6;TRPV1;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,sulfotransferase activity (GO:0008146),0.570368997227622,1.7184393543166328,0.005660377358490566,0.26250029974755057,0.94,6/33,4.36%,HS3ST3A1;UST;CHST4;CHST15;HS6ST1;CHST10
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5079732656455912,1.7153083158078397,0.005119453924914676,0.25016105155338925,0.943,13/55,9.21%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC23A2;SLC23A1;SLC16A12;SLC38A1;PDPN;SLC19A1;SLC38A9
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5073352955557076,-1.7134727838695745,0.0,0.26314865220827116,0.835,15/42,13.17%,STXBP6;PDLIM5;BSG;ESAM;CD200;PALLD;NPTN;ANXA1;ROBO4;TMOD3;PPP1CA;S100A11;DSCAML1;JAM3;EMB
prerank,CARD domain binding (GO:0050700),-0.6427602459472652,-1.6838167478749675,0.008421052631578947,0.3132722050098466,0.917,9/14,23.22%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4;RIPK2;CASP1;BCL10
prerank,actin binding (GO:0003779),-0.3876011322444628,-1.682671082182513,0.0,0.28478983480300546,0.918,36/170,11.65%,UTRN;SYNE1;ACTN4;PDLIM5;MYRIP;CALD1;ABLIM1;VCL;MICAL2;NOS3;TMSB4X;FXYD5;GSN;PARVB;SMTN;MYH9;MACF1;MTSS1;SSH2;ITGB1;CAP2;EPS8;MSRB2;KLHL2;ALDOA;CEACAM1;TPM2;SYNPO2;CAP1;MYO19;EPS8L2;MYO1F;TMSB10;PARVA;LIMA1;LDB3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.659227508575257,1.6825804126563078,0.012295081967213115,0.3094924054306814,0.975,2/15,0.80%,CCR9;ACKR2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5706648679407973,-1.676341363831143,0.008639308855291577,0.2740477539845351,0.926,8/23,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6307250554104945,-1.6641263652427034,0.013916500994035786,0.25783409671371743,0.947,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6307250554104945,-1.6641263652427034,0.013916500994035786,0.25783409671371743,0.947,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,alkali metal ion binding (GO:0031420),0.683225597872082,1.6605529107689498,0.022132796780684104,0.3449489126812646,0.983,5/13,13.52%,ATP1A2;CAPN3;ACAT1;DRG1;HDAC4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5753867165313281,1.6562961776885126,0.019011406844106463,0.33573886518714685,0.986,7/26,4.48%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A11;SLC16A12;MPC2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7215884725656709,1.6562760592005399,0.013725490196078431,0.3171414989435564,0.986,1/10,0.04%,PRKAG2
prerank,Tat protein binding (GO:0030957),-0.6971847638892992,-1.655006232292861,0.014028056112224449,0.259882880186933,0.955,3/10,4.30%,ACTB;MDFIC;DNAJA1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.5354468832452491,-1.6543303223311705,0.016359918200409,0.2439797799882092,0.955,11/28,20.49%,DAB2IP;TRAF5;TRIM37;CASP8AP2;FEM1B;BABAM2;MADD;TMBIM1;RIPK1;MYD88;TRAF4
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.41568454347129596,-1.651940413571096,0.002544529262086514,0.2348271515121107,0.959,23/100,10.77%,HIP1;CYTH3;MYO10;PLA2G4A;DAB2IP;MYO1B;ARAP2;PARD3;CERT1;IQGAP1;WIPI1;ARAP3;ANKFY1;SNX13;PLEKHA8;ARAP1;SH3PXD2B;OSBP;PLEKHA4;ZFYVE16;GOLPH3;PLEKHA5;JPH2
prerank,phospholipid transfer activity (GO:0120014),-0.5832019175942681,-1.6518016735463656,0.012526096033402923,0.22119308694590314,0.959,16/21,28.25%,PITPNC1;CERT1;PLTP;PLEKHA8;TNFAIP8L3;MTTP;ABCA3;PRELID3B;PITPNB;GLTP;TRIAP1;C2CD2L;PRELID2;PLEKHA3;PITPNM1;CPTP
prerank,calcium:sodium antiporter activity (GO:0005432),0.7125108106426146,1.64896738997222,0.03434343434343434,0.3193447516369045,0.987,2/10,0.73%,SLC8A3;SLC24A3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.44170628861009625,-1.6349860420523994,0.004819277108433735,0.24373142004189507,0.978,20/60,15.76%,NRP1;ROR1;TEK;NTRK3;NRP2;TIE1;INSR;MERTK;EGFR;CRIM1;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2;FGFRL1;ALK;CSF1R
prerank,fatty acid synthase activity (GO:0004312),-0.6842831544104765,-1.6305263643139984,0.017892644135188866,0.23881769574520198,0.979,6/10,18.46%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;ELOVL4;MCAT
prerank,CoA-ligase activity (GO:0016405),0.646624673862552,1.6270280028624102,0.029880478087649404,0.36220868672535933,0.995,4/14,9.63%,ACSL1;ACSM2A;ACSM2B;ACSS2
prerank,cyclic nucleotide binding (GO:0030551),-0.5602901315835795,-1.6217159407847868,0.03508771929824561,0.24491112978688712,0.984,5/21,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.6514960537922867,1.610802369096656,0.025341130604288498,0.38948382625218386,0.997,5/13,10.60%,ALDH1A2;ALDH1L1;ALDH7A1;ALDH1A1;ALDH2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7053888664619647,1.6107866785366425,0.027083333333333334,0.3718696771318591,0.997,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6593176943242651,-1.599228572127848,0.029013539651837523,0.2840495931448354,0.991,5/11,7.63%,ATP10A;ATP8B1;ATP8A1;ATP11C;ABCA3
prerank,SUMO binding (GO:0032183),-0.6340882212843583,-1.5950218282027242,0.028747433264887063,0.28055950546950637,0.992,5/13,9.03%,RNF111;HERC2;SERBP1;CASP8AP2;USPL1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6091617970120774,1.5945016590421222,0.03762376237623762,0.4031282876733777,0.999,5/16,13.53%,IDO1;ETHE1;ADI1;HAAO;CDO1
prerank,lipase activity (GO:0016298),0.49787310706668564,1.5926625689935263,0.018018018018018018,0.3912626396995854,0.999,11/43,11.81%,CEL;LIPA;DDHD2;ABHD5;PLA1A;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3
prerank,outward rectifier potassium channel activity (GO:0015271),0.6626997702445541,1.5881383460944138,0.046,0.3882758768959549,0.999,4/11,7.16%,KCNK2;KCND3;KCNT1;KCND2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.63121380960199,-1.5811754024593243,0.04660194174757282,0.29928355190717426,0.996,3/12,2.68%,DAB2IP;VEGFC;ITGA5
prerank,ligand-gated channel activity (GO:0022834),0.5235953134930852,1.578681308254664,0.029069767441860465,0.39978188714442703,0.999,7/29,8.71%,ANXA6;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.5024341169456837,-1.5777630266294156,0.013157894736842105,0.2944335386274977,0.997,11/30,14.78%,GAS6;CAST;RPS6KA3;CARD16;CST3;XIAP;TNFAIP8;SERPINB9;BIRC3;PTTG1;MT3
prerank,store-operated calcium channel activity (GO:0015279),-0.6762263508406238,-1.5754338806553672,0.027777777777777776,0.28745180186395397,0.998,5/10,9.94%,STIM2;TRPC3;TRPC6;TRPC4;TRPC1
prerank,semaphorin receptor binding (GO:0030215),-0.5348117305409889,-1.5734479067856784,0.024242424242424242,0.2809680441605984,0.998,13/23,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,death receptor binding (GO:0005123),-0.5943714805866459,-1.5733779432333554,0.021696252465483234,0.27078760207217495,0.998,11/15,31.52%,DAB2IP;NGF;CASP8AP2;FEM1B;MADD;TMBIM1;RIPK1;MYD88;EDA;FADD;PIDD1
prerank,triglyceride lipase activity (GO:0004806),0.577022512049278,1.571246235664943,0.0392156862745098,0.4053581218355961,1.0,4/20,11.37%,CEL;DDHD2;ABHD5;PLA2G15
prerank,phospholipase C activity (GO:0004629),-0.5306318358653674,-1.5683391951554575,0.015350877192982455,0.2710953641268607,0.998,6/25,4.44%,PLCB4;EDNRA;PLCE1;PLCL1;PLCG1;PLCG2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.665505031835373,1.5640630681129108,0.05309734513274336,0.40993724556158045,1.0,1/11,0.05%,PPP1R1A
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4159227087172996,-1.550864443974821,0.007518796992481203,0.301371948648056,1.0,17/60,12.90%,ROR1;TEK;NTRK3;ACVR1;ACVRL1;TIE1;INSR;MERTK;EGFR;TGFBR2;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.638269080631704,-1.550028063666917,0.03718199608610567,0.2931550493584035,1.0,5/11,21.79%,MAP3K5;EGFR;MAP3K20;MAP3K6;MAP3K4
prerank,ion channel activity (GO:0005216),0.43549434027995343,1.5481583397437892,0.010452961672473868,0.44035380162155374,1.0,13/80,8.71%,TRPM3;ANXA6;TRPM6;TRPV1;TMEM120B;GRIN3A;GRID2;GRIN2D;NALCN;GRIK5;GRIK2;UNC80;CHRNB2
prerank,N-acetyltransferase activity (GO:0008080),0.5723296625538052,1.5380710610621715,0.06343283582089553,0.4535539861187254,1.0,4/19,6.56%,GNPNAT1;SAT1;ATAT1;NAT2
prerank,voltage-gated potassium channel activity (GO:0005249),0.42049700993558947,1.5277393404101642,0.021885521885521887,0.47083390982222645,1.0,14/80,10.77%,KCNK2;KCND3;KCNA3;KCNT1;KCNJ13;LRRC38;KCNJ5;KCNJ10;KCNC3;KCND2;KCNH2;KCNC2;KCNJ16;KCNH7
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6007811487724786,-1.5253771723841858,0.055666003976143144,0.33771126072412827,1.0,7/12,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.44280527661348296,-1.5189816355082881,0.021691973969631236,0.34319181729237486,1.0,23/42,28.81%,BCAR3;YWHAE;PIK3R1;SHE;YWHAB;PLCG2;VAV2;YES1;PFN1;FBXW7;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;NEDD4;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,BMP binding (GO:0036122),-0.6210798157331735,-1.5158560565624828,0.06349206349206349,0.3401197099502482,1.0,3/11,2.04%,BMPR2;GREM2;ENG
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5434767173881703,-1.51560085706838,0.05919661733615222,0.33086326110038367,1.0,7/18,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5464593331930898,-1.5141515198724642,0.03483606557377049,0.32486448614040403,1.0,6/18,9.92%,STXBP6;PDLIM5;ANXA1;TMOD3;PPP1CA;S100A11
prerank,cGMP binding (GO:0030553),-0.6220151984370268,-1.5057668007882117,0.05521472392638037,0.3357939365051491,1.0,3/11,6.37%,RAPGEF2;PDE10A;PDE2A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3463803924148636,-1.4985487936328619,0.0026954177897574125,0.3444026292388747,1.0,56/173,21.37%,KLF12;FOXP1;ZBTB16;ZFHX3;ELK3;TRPS1;ZEB1;LRRFIP1;FOXP2;PLAGL1;PPARD;TBX3;FOXO3;CTCF;PRDM16;TBX18;ZNF25;DACH1;JUN;BHLHE40;CREB3L1;KLF8;HES1;ZNF3;JDP2;TGIF1;ZNF436;HEYL;NACC2;PRDM5;ZBTB1;HEY2;MAFK;ETV6;ETS2;SREBF2;HHEX;TBX2;NACC1;NFIL3;ZBTB5;SKIL;SP2;ZBTB33;ZFP57;BCL6B;HEY1;ZBTB37;NR2F1;PRDM1;ZNF177;NFATC3;ATF3;ZBTB25;ZBTB45;THAP1
prerank,leak channel activity (GO:0022840),0.5598848857896945,1.497651282592506,0.0762081784386617,0.5504635079063067,1.0,3/18,5.43%,KCNK2;TMEM175;NALCN
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5670717913334733,1.495961178819678,0.06476190476190476,0.539341787705166,1.0,6/18,10.60%,ALDH1A2;ALDH8A1;ADH4;ALDH1A1;ALDH3B1;ALDH2
prerank,chemorepellent activity (GO:0045499),-0.5007614111622908,-1.4937665579575512,0.034623217922606926,0.34729098186681917,1.0,14/25,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;EPHA7;SEMA4D;SEMA4F;SEMA6B
prerank,MAP kinase activity (GO:0004707),0.6024531223483427,1.4920727990978464,0.06336633663366337,0.5362423243346809,1.0,5/14,12.42%,MAPK4;MAPK6;MAPK10;MAPK14;MAPK9
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5087227210243017,-1.4895820342614252,0.037199124726477024,0.3492236098259454,1.0,5/23,4.44%,PLCB4;EDNRA;PLCE1;PLCG1;PLCG2
prerank,transforming growth factor beta binding (GO:0050431),-0.4997001148492226,-1.487036186967357,0.04291845493562232,0.34691933319117446,1.0,10/23,9.46%,LTBP4;LTBP1;ACVR1;ACVRL1;ENG;THBS1;TGFBR2;CD109;VASN;TGFB3
prerank,actin monomer binding (GO:0003785),-0.5041196255969845,-1.481821372136532,0.05230125523012552,0.35003057843882,1.0,7/22,16.89%,NOS3;TMSB4X;MTSS1;TMSB10;LIMA1;PFN1;MYL4
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6434856606529059,1.4787801033960324,0.05148514851485148,0.5616964506464328,1.0,3/10,1.76%,CACNA1D;CACNB1;CACNB3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3913530294724685,-1.4784247383501232,0.020356234096692113,0.3494376062831841,1.0,23/72,16.64%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;SNX18;FCHO2;PLEKHA4;KCNQ1;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2;LDLRAP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5486571117040298,1.4771146067966892,0.07518796992481203,0.5520662012104012,1.0,7/20,12.87%,LPGAT1;AGPAT4;ABHD5;MOGAT1;PLA2G15;DGAT2;LCLAT1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3443058929848529,-1.4766504872131143,0.005063291139240506,0.34546973547069515,1.0,33/147,10.02%,DOCK9;CYTH3;PREX2;FARP1;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;FGD6;RAP1A;BCR;SPATA13;RASGRF2;DENND6A;HERC2;MON1A;ARHGEF2;ARHGEF15;RAPGEF4;RAPGEF6;DOCK2;EIF2B2;GAPVD1;ABR;TIAM1;VAV2;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B
prerank,C-C chemokine receptor activity (GO:0016493),0.5339837328288672,1.4750452073821583,0.058027079303675046,0.543996090643838,1.0,2/21,0.80%,CCR9;ACKR2
prerank,LRR domain binding (GO:0030275),0.6037985585198241,1.4709191603229965,0.04801670146137787,0.5425279050281384,1.0,2/14,2.44%,ROBO1;PAWR
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5370300963663032,1.470323253875474,0.0695970695970696,0.5304124553858501,1.0,4/21,8.71%,P2RX6;TRPV1;GRIK2;CHRNB2
prerank,SH3 domain binding (GO:0017124),-0.4000691728832075,-1.4686795549810807,0.022321428571428572,0.3570148571246122,1.0,18/62,14.93%,AFAP1L1;ABI1;SHANK3;DAB2IP;CBLB;PTPN12;WASF2;AFAP1L2;PLSCR1;WIPF1;SGIP1;ABI3;GPX1;CD2AP;LANCL1;ADAM15;ARHGAP27;CBL
prerank,voltage-gated cation channel activity (GO:0022843),0.3952531629524894,1.4686423589297102,0.023769100169779286,0.5226506148752512,1.0,15/97,9.39%,CACNA1D;CACNA2D3;KCND3;CACNG7;KCNA3;CACNB1;CACNB3;LRRC38;GRIN3A;CACNA2D2;GRIN2D;KCNC3;KCND2;KCNH2;KCNC2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.626008311946976,-1.4664037028184265,0.08447937131630648,0.35504183234449277,1.0,2/10,3.32%,MECOM;PRDM16
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4445870958290245,1.4656810090478274,0.0466786355475763,0.5196214343226344,1.0,11/49,15.10%,ATP1A2;DUSP11;PXYLP1;PRUNE1;ARMT1;MPPED2;ACP6;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,death domain binding (GO:0070513),-0.6093564377247147,-1.457400364843651,0.059063136456211814,0.36859364680641504,1.0,7/11,19.77%,BCL2L1;DAPL1;CRADD;RACK1;DAP;MCL1;RIPK1
prerank,C-C chemokine binding (GO:0019957),0.5132799109697374,1.4524716753517517,0.06133828996282528,0.547240509283787,1.0,2/22,0.80%,CCR9;ACKR2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5052352415817709,-1.4458702227382874,0.08536585365853659,0.3885944444340657,1.0,6/19,13.67%,ABI1;GAS6;AFAP1L2;PAK2;EFNA5;CD24
prerank,GTPase activator activity (GO:0005096),-0.30869934695815027,-1.4442892462129884,0.003003003003003003,0.3845416316495867,1.0,67/313,10.07%,ARHGAP31;NRP1;DOCK9;CYTH3;ARHGAP10;PREX2;TBC1D4;CHN2;FARP1;RABGAP1L;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;ARHGAP42;RGS3;FGD6;RGS5;SIPA1L2;RASGRP3;RAP1A;STARD8;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;SPATA13;RASGRF2;ARAP3;DENND6A;STARD13;TBC1D12;HERC2;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;MON1A;ARHGEF2;SIPA1L3;ARHGEF15;ARHGAP32;TBC1D1;ARHGAP35;RAPGEF4;RAPGEF6;RGS6;DOCK2;EVI5L;EIF2B2;SEC23A;GAPVD1;ABR;TIAM1;VAV2;TBC1D13;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B;RP2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5922644600127973,-1.4413169476784085,0.06324110671936758,0.3841169948907275,1.0,2/12,2.85%,PIEZO2;PIEZO1
prerank,ADP binding (GO:0043531),0.502809296216317,1.4394555470447195,0.06386861313868614,0.5752722827906177,1.0,7/25,10.19%,PRKAG2;MYO9B;PGK1;MYO3A;MSH6;ABCD1;MYO18A
prerank,sialyltransferase activity (GO:0008373),-0.4954124577108573,-1.4369102224169754,0.059574468085106386,0.38696060108124386,1.0,11/20,19.98%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;ST3GAL1;ST6GALNAC5;ST8SIA6;ST8SIA2;ST6GALNAC2;ST3GAL2;ST6GAL2
prerank,potassium ion leak channel activity (GO:0022841),0.5569491224392951,1.436001658736641,0.083984375,0.5729348371000794,1.0,2/15,4.96%,KCNK2;TMEM175
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.5736741909652546,-1.434497354291183,0.09650924024640657,0.3849911199882534,1.0,5/12,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5605341389943237,-1.4344614711520447,0.07773109243697479,0.37772421625262087,1.0,7/13,13.82%,IL1R1;ITGA5;PTPRJ;ERN1;PDGFC;PDGFD;VEGFA
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.47222708273938474,-1.4246843418440165,0.09090909090909091,0.3949242648898225,1.0,11/26,29.96%,CSGALNACT1;B3GNT2;CHSY3;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,syntaxin binding (GO:0019905),0.4132344218358104,1.424480628351045,0.05291005291005291,0.5984703365689531,1.0,18/61,12.83%,UNC13C;SYT12;SYT9;NAPB;SYT1;STX16;SNAP29;SNAP47;STXBP5L;NAPA;LRRK2;GOLGA2;SNAP25;NSF;SYT10;STXBP4;TMED9;CPLX1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.545195587752044,-1.4240569357931294,0.100418410041841,0.3892289552575794,1.0,5/14,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.4285904253180724,-1.417495941040987,0.050808314087759814,0.39785416094135034,1.0,10/38,10.77%,HIP1;PLA2G4A;DAB2IP;PARD3;WIPI1;SNX13;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2
prerank,amyloid-beta binding (GO:0001540),-0.37044517390769377,-1.4142174125996894,0.011627906976744186,0.39813389575691543,1.0,22/79,18.83%,APBB2;COL25A1;FZD6;TGFB2;INSR;ITM2A;BCHE;CST3;IAPP;GRIN2B;APOE;EPHB2;CACNA1B;CD74;FZD4;GSAP;ITM2B;LRP1;APBB3;LDLRAP1;GRIN1;PFDN6
prerank,anion channel activity (GO:0005253),-0.3789503774361078,-1.413887546245294,0.04194260485651214,0.39211163390080256,1.0,16/61,16.14%,SLC26A7;LRRC8D;CLIC4;ANO1;LRRC8C;LRRC8A;CLIC1;GABRA3;GLRB;CLCC1;LRRC8B;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5904287622297901,1.4136238505643337,0.08793456032719836,0.6214376284398031,1.0,5/12,9.99%,SLC25A42;SLC25A5;SLC19A1;SLC25A25;SLC25A23
prerank,hydro-lyase activity (GO:0016836),0.4412409460820415,1.4069644443557296,0.06440071556350627,0.6318231449162894,1.0,11/41,10.93%,HACD3;ENO1;ACO1;NAXD;ENO4;HACD4;HACD1;FAHD2A;ECHDC3;ECHS1;ECHDC2
prerank,methyl-CpG binding (GO:0008327),0.508337558972,1.4053535355467148,0.08298755186721991,0.6240024737441819,1.0,4/22,4.65%,CXXC5;ZBTB38;CXXC4;TET1
prerank,potassium channel activity (GO:0005267),0.3879129710070929,1.404086714371632,0.0387858347386172,0.6152128205921343,1.0,20/89,16.88%,KCNK2;KCND3;KCNA3;KCNT1;LRRC38;TMEM175;KCNC3;GRIK5;GRIK2;KCND2;KCNH2;KCNC2;KCNN4;KCNH7;KCNK4;KCNS3;TMEM38A;KCNA4;KCNQ3;KCNK10
prerank,voltage-gated calcium channel activity (GO:0005245),0.4501596218444647,1.4039133444251437,0.07321428571428572,0.6034608769497027,1.0,6/37,4.27%,CACNA1D;CACNA2D3;CACNG7;CACNB1;CACNB3;CACNA2D2
prerank,protein tyrosine kinase activity (GO:0004713),-0.3430204156275574,-1.4031632952760107,0.028089887640449437,0.41080409019678915,1.0,25/108,12.90%,ROR1;TEK;NTRK3;HIPK1;TIE1;INSR;MERTK;PEAK1;EGFR;KDR;BMX;TEC;MET;LYN;FLT1;SCYL1;SRC;FLT4;JAK1;YES1;EPHB2;DYRK1A;RET;PTK2B;ROR2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.581155791616457,1.4004756039400261,0.12681912681912683,0.6040437448373095,1.0,4/13,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,frizzled binding (GO:0005109),0.4474154950665457,1.397842671334556,0.07720588235294118,0.6005263360265134,1.0,6/34,9.38%,RNF43;WNT4;WNT5B;WNT7A;WNT6;FZD7
prerank,acylglycerol lipase activity (GO:0047372),-0.5775914602763284,-1.3958268571011347,0.09504950495049505,0.42152690980656116,1.0,3/11,12.54%,ABHD2;MGLL;ABHD6
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.39764831317353844,1.3956057690586783,0.06304728546409807,0.595634337038689,1.0,12/73,10.90%,LGR4;GCGR;PTH2R;NPR3;BDKRB1;OPRD1;CRHR1;BDKRB2;NMUR1;LTB4R2;GPR37;GRPR
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5025415765326573,-1.3946043532084633,0.08620689655172414,0.41773578515610305,1.0,7/18,14.78%,GAS6;RPS6KA3;XIAP;TNFAIP8;SERPINB9;BIRC3;MT3
prerank,cell adhesion mediator activity (GO:0098631),-0.4795686773447427,-1.394453796471999,0.09603340292275574,0.41130405833477096,1.0,9/24,13.17%,BSG;ESAM;PALLD;NPTN;ROBO4;DSCAML1;BCAM;JAM3;EMB
prerank,BMP receptor binding (GO:0070700),0.5811590708592067,1.3938628113474631,0.12298387096774194,0.5898824574625686,1.0,4/12,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,death receptor activity (GO:0005035),-0.5886059416818795,-1.392053299392801,0.10526315789473684,0.41050403149938924,1.0,5/11,12.55%,TNFRSF1B;FAS;TNFRSF11A;EDA2R;TNFRSF19
prerank,gated channel activity (GO:0022836),-0.5508204264631711,-1.3853711858073074,0.09839357429718876,0.4204862909251856,1.0,2/14,2.85%,PIEZO2;PIEZO1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5535980976697522,-1.3849493493823224,0.11801242236024845,0.4146940813817845,1.0,5/13,10.62%,PIP5K1B;PIP4K2A;PIK3C2A;PIK3CA;PIK3CD
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3988607824755621,-1.3785174081002487,0.05217391304347826,0.42397648010081057,1.0,19/46,27.74%,GCNT2;EXT1;B3GNT2;MGAT5;MGAT4A;HEXA;GCNT1;MFNG;MGAT4B;LFNG;B3GNT3;B3GALT5;PIGQ;B3GNT8;MGAT3;EXT2;GCNT4;RFNG;B3GALT1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.34998973634936187,-1.3759740582104034,0.03116883116883117,0.423971980254358,1.0,25/91,15.58%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;WIPI1;SNX18;FCHO2;SH3PXD2B;PLEKHA4;KCNQ1;PLEKHA5;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2
prerank,GDP binding (GO:0019003),-0.37136931462722056,-1.3737882370424803,0.04926108374384237,0.42311840568865217,1.0,28/63,26.43%,RAB14;RAP1A;RAB31;RALB;RAP2A;RASL12;RAB22A;KRAS;NRAS;GNAI3;RAB27A;RERG;NME2;RAB11B;RAB5C;RAP2B;MRAS;ARL8B;RRAGD;RAB27B;MIEF1;RAB35;RAB3B;RAB9B;RAB5B;TRIM23;RASEF;RHEBL1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.5421698195037528,-1.3700221552447054,0.11350293542074363,0.42610000361545974,1.0,6/13,28.79%,SREBF2;ECI1;ECH1;IDI1;DDT;MIF
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5013061011346689,1.368633075496935,0.10721247563352826,0.6605517264293749,1.0,3/21,3.86%,FGF1;FGF4;FGF9
prerank,muscle alpha-actinin binding (GO:0051371),-0.5158302709036736,-1.3683730604819475,0.09411764705882353,0.42359114084692157,1.0,4/15,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,nucleosomal DNA binding (GO:0031492),-0.4628947668890682,-1.3683025446317825,0.09327548806941431,0.41768498425799333,1.0,5/21,8.41%,ACTB;H3-3A;SMARCC1;GATAD2B;RBBP4
prerank,cardiolipin binding (GO:1901612),0.5820858521301647,1.36610687506113,0.13673469387755102,0.6566111182774893,1.0,3/10,17.58%,GSDME;GSDMD;UQCC3
prerank,protein tyrosine kinase binding (GO:1990782),-0.36097087752409535,-1.3614178353541213,0.054373522458628844,0.42795821376586857,1.0,17/71,11.52%,BMPR2;CBLB;ACVR1;GAS6;GRB14;CPNE3;ITGB1;ANGPT2;TJP2;RACK1;NCK1;CEACAM1;PTPN1;SOCS5;NEDD9;DUSP3;SQSTM1
prerank,chemokine receptor activity (GO:0004950),0.47487037805126897,1.3611030813047094,0.10556621880998081,0.661702535332602,1.0,2/24,0.80%,CCR9;ACKR2
prerank,neurexin family protein binding (GO:0042043),0.5957997315155212,1.357739434636512,0.15308151093439365,0.6617550410837343,1.0,4/10,7.03%,CEL;NLGN2;SYTL3;NLGN3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4537775999959788,1.356798030435171,0.10676156583629894,0.6537317031887773,1.0,2/29,1.98%,PRKAG2;CDKN2A
prerank,receptor tyrosine kinase binding (GO:0030971),-0.372281369876315,-1.3520623264615736,0.04935622317596566,0.444267965329955,1.0,17/56,16.25%,CBLB;GAS6;PIK3R1;GRB14;CPNE3;ANGPT2;RACK1;NCK1;PTPN1;SOCS5;DUSP3;SQSTM1;SH2B2;IRS1;CBL;DOCK4;SHC4
prerank,monocarboxylic acid binding (GO:0033293),0.5059029149272489,1.3511423283316135,0.138,0.6615424822900878,1.0,5/18,16.37%,CYP26B1;NR2F2;RXRA;PYGL;RARA
prerank,epidermal growth factor receptor binding (GO:0005154),-0.4433074219691445,-1.3501299872179446,0.10515873015873016,0.4428724870824132,1.0,9/25,28.19%,HIP1;PLSCR1;SNX1;SNX2;EFEMP1;FAM83B;EGF;GRB2;BTC
prerank,sterol binding (GO:0032934),0.3959502614706599,1.3474324712293086,0.0846286701208981,0.663050186205415,1.0,12/56,9.10%,RORA;OSBPL8;ANXA6;SOAT2;SIDT1;INSIG2;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,myosin binding (GO:0017022),-0.370938110406037,-1.3426746474641669,0.08393285371702638,0.4545581983021618,1.0,10/55,7.50%,MYRIP;CALD1;SHROOM4;SPATA6;RHOA;GSN;RAB14;RAB6A;NKD2;MYOC
prerank,lysine N-methyltransferase activity (GO:0016278),0.4922146027305584,1.342341455377634,0.137291280148423,0.6683907152172609,1.0,6/20,13.15%,KMT5A;EEF2KMT;ANTKMT;SETD4;SETD7;SMYD2
prerank,insulin-like growth factor I binding (GO:0031994),-0.5321544478697261,-1.3397820819430268,0.13562753036437247,0.455717923309459,1.0,4/13,5.13%,ITGA6;INSR;ITGB4;IGFBP6
prerank,kinase activator activity (GO:0019209),0.4480444580171652,1.3396414829858048,0.11586452762923351,0.6659846236823889,1.0,4/30,4.06%,PRKAG2;GPRC5A;GPRC5C;GPRC5B
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30112395970629574,-1.3385275465955142,0.019498607242339833,0.4528499006758269,1.0,66/196,24.01%,RHOJ;RAPGEF2;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;PDE10A;GNL3;GBP4;RAP2A;GCH1;GBP5;PDE2A;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;ARL5A;NME2;RAB11B;RAB5C;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;MIEF1;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2;RAB3B;RAB9B;RAB5B;TRIM23
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4603132267012798,-1.3372592322616732,0.10759493670886076,0.44988483663646417,1.0,7/23,12.45%,HIP1;WIPI1;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2;HIP1R
prerank,glutamate receptor binding (GO:0035254),-0.48026332708247244,-1.3281973129225066,0.13026819923371646,0.4662219859339888,1.0,2/17,0.56%,HIP1;SHANK3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5518161189917876,1.3252367748836156,0.15808823529411764,0.7029197084582971,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,retinoid X receptor binding (GO:0046965),-0.5396568720624403,-1.324731089412341,0.14545454545454545,0.46878297116423845,1.0,6/11,14.83%,TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,phosphotyrosine residue binding (GO:0001784),-0.39740654203969733,-1.3232609063170557,0.09761388286334056,0.46650464734141966,1.0,19/37,28.81%,BCAR3;PIK3R1;SHE;PLCG2;VAV2;YES1;PFN1;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.42762869669688874,1.3199463402934004,0.1258741258741259,0.7088570233125039,1.0,10/34,13.73%,KMT5A;EEF2KMT;DOT1L;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2;MEN1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4028121720246065,1.3194032397278506,0.09416195856873823,0.7001640286251206,1.0,10/49,7.90%,SYT11;SYT12;ANXA6;CPNE1;ANXA5;SYT9;CPNE4;PLA2G4C;SYT1;SYT13
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5251418399478847,1.3188960882018563,0.14566929133858267,0.6914066755454884,1.0,6/15,24.14%,P2RX6;GPR87;P2RX4;PTAFR;GPR34;P2RY12
prerank,acetylation-dependent protein binding (GO:0140033),0.4847505350345301,1.3168793645241912,0.14836223506743737,0.677412183434979,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,lysine-acetylated histone binding (GO:0070577),0.4847505350345301,1.3168793645241912,0.14836223506743737,0.677412183434979,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,kinase binding (GO:0019900),-0.27237073409739276,-1.3144564620750083,0.0036231884057971015,0.4818810130075386,1.0,88/435,13.98%,UTRN;TTC28;ACTB;LIMS1;GHR;FRMD5;CAV1;SLC12A7;SLC12A2;PDE8A;DAB2IP;PTN;RHOBTB1;RHOA;BCAR3;GSN;ACVRL1;PKD1;IQGAP1;EGFR;FOXO3;BCL2L1;PLCG1;BTG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;STX1A;ESR1;CACUL1;PLCG2;FAS;FLNA;CAB39;CARD16;SPRED2;TFRC;SMAD1;PIK3IP1;PAK2;CIT;ADAM10;EEF2;MIDN;TRIM14;PRKCD;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;EMP2;CEACAM1;ACTA2;HDAC7;SRC;PTPN1;TIAM1;PFKL;BCAR1;CIR1;RPTOR;DUSP3;YWHAZ;PER1;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GSKIP;RND3;TRPV4;PEBP1;PTPRC;CD24;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3736765949047393,1.3093399787109836,0.09581881533101046,0.6920112670822143,1.0,17/69,12.98%,LPGAT1;SPHK1;ASPG;SOAT2;PLAAT5;ZDHHC12;PLA2G4C;DBT;GLYAT;SOAT1;MOGAT1;ZDHHC1;ZDHHC16;PLA2G15;ZDHHC6;DGAT2;ZDHHC3
prerank,neuropeptide binding (GO:0042923),0.49029115555502023,1.30766592348482,0.16165413533834586,0.6874877080211607,1.0,7/18,24.16%,OPRD1;NMUR1;GPR37;OPRM1;GPR149;OPRL1;NMUR2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.464917867088812,1.3047267882536508,0.13565891472868216,0.6875691256899131,1.0,4/22,8.69%,CPEB2;ELAVL4;EXOSC8;ELAVL1
prerank,amino acid binding (GO:0016597),-0.403801922498652,-1.3043687864990456,0.0931174089068826,0.5021730730459093,1.0,21/31,32.22%,NOS3;GRM7;SRR;GLRB;GRIN2B;GCLC;DDAH1;GLRA2;THNSL2;CAD;GRIN1;ASS1;DDAH2;AARS2;SHMT2;CASTOR1;AGXT;SHMT1;GNMT;NOS2;NOS1
prerank,acetyltransferase activity (GO:0016407),0.42524375849077056,1.2993279627698595,0.12920353982300886,0.6957951962981435,1.0,5/31,4.93%,SPHK1;GNPNAT1;SAT1;DBT;ACAT1
prerank,hormone receptor binding (GO:0051427),-0.49380982662001094,-1.2967852628772072,0.15904572564612326,0.5149864538494657,1.0,6/14,21.50%,SOCS2;JAK1;NCOA6;NPPC;PTHLH;CCK
prerank,cation channel activity (GO:0005261),0.35581671345320065,1.2949025646577292,0.0967741935483871,0.7009334183420738,1.0,6/94,1.13%,TRPM3;CACNA1D;ANXA6;SLC24A3;TRPM6;TRPV1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.35929829164937155,1.2948450194907049,0.09228187919463088,0.6917322927752159,1.0,18/74,15.83%,NADK2;SPHK1;GK;FAM20A;TKFC;PANK1;PIK3CB;NT5C3A;PANK2;TRPT1;DGKI;CHKB;PI4KA;SPHK2;DGKE;DGKD;IPPK;HK1
prerank,receptor antagonist activity (GO:0048019),0.4937860263332525,1.2933838573492544,0.16568047337278108,0.6874321433562298,1.0,3/17,11.01%,ADH7;DKK3;FST
prerank,protein phosphatase 1 binding (GO:0008157),0.4701655278641887,1.2910018863276485,0.1626984126984127,0.6854980239642757,1.0,4/21,7.65%,SH3RF2;PPP1R3F;PPP1R16A;PHACTR4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5123357970282734,-1.2876401321930313,0.17365269461077845,0.5337601982578966,1.0,7/12,32.24%,BRD4;MAPK1;CDK6;CDK8;CDK13;CDK19;CDK1
prerank,translation initiation factor activity (GO:0003743),-0.3903402929977487,-1.2873032470587888,0.13333333333333333,0.5285803565433549,1.0,12/36,17.56%,EIF3E;EIF3H;EIF3M;EIF2B2;MTIF3;EIF4E;EIF3F;AGO2;EIF1B;EIF3K;EIF4G3;EIF2B1
prerank,GTPase regulator activity (GO:0030695),-0.2877797559251262,-1.2865199034836614,0.025280898876404494,0.5247969057979534,1.0,43/212,9.52%,ARHGAP31;NRP1;ARHGAP10;PREX2;TBC1D4;CHN2;RABGAP1L;DOCK1;RAPGEF2;ARHGAP42;SLIT2;RGS3;RGS12;RGS5;SIPA1L2;RASGRP3;STARD8;SH3BP4;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;ARAP3;STARD13;TBC1D12;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;SIPA1L3;ARHGAP32;TBC1D1;ARHGAP35;RGS6;EVI5L;IPO7;SEC23A;ABR;PDE6D;TBC1D13
prerank,GTP binding (GO:0005525),-0.2922225377823616,-1.285313758610398,0.032520325203252036,0.5221398056287134,1.0,55/172,22.95%,RHOJ;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;GNL3;GBP4;RAP2A;GCH1;GBP5;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;RRAGA;RAB27A;RND3;RERG;ARL5A;RAB11B;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.45018465400036123,-1.283937851771932,0.14754098360655737,0.5140137614129373,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.45018465400036123,-1.283937851771932,0.14754098360655737,0.5140137614129373,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,metallocarboxypeptidase activity (GO:0004181),0.4406551467078723,1.2810569810030514,0.16387337057728119,0.7073852008225899,1.0,4/26,8.89%,AEBP1;CPN1;AGBL4;CPA2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5276049035054313,-1.2778024762226636,0.16901408450704225,0.5240394867227776,1.0,2/11,3.62%,SLC9A2;SLC9B2
prerank,calcium channel activity (GO:0005262),0.35410673946898674,1.277791129310912,0.11222780569514237,0.709180082875082,1.0,8/84,1.76%,CACNA1D;CACNA2D3;ANXA6;SLC24A3;CACNG7;TRPV1;CACNB1;CACNB3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5372398338531728,-1.2762211377354717,0.18837675350701402,0.5224342031536944,1.0,4/10,3.06%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1
prerank,Wnt-activated receptor activity (GO:0042813),-0.475317023621032,-1.2752508501186253,0.16735537190082644,0.519328746436711,1.0,7/15,13.72%,ROR1;FZD6;LRP5;PKD1;FZD4;TSPAN12;FZD1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5495784682385281,1.2752238191932856,0.203125,0.7089082336310963,1.0,4/11,11.47%,TRPV1;ITPR1;RYR2;TRPM2
prerank,transcription coactivator binding (GO:0001223),0.46972374639015746,1.2710671996479934,0.17315175097276264,0.7134161700300204,1.0,7/20,13.37%,RORA;SMAD3;THRB;CCNT2;MED25;ZBTB49;TERT
prerank,histone methyltransferase binding (GO:1990226),0.5439362512313338,1.270991633475836,0.1980392156862745,0.7049805826108182,1.0,3/11,10.72%,CBX1;PHF1;LCOR
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.43978245284824624,1.2705755149158837,0.16257088846880907,0.6976988867463145,1.0,5/27,6.01%,SLC22A6;SLC22A8;SLC5A5;SLC26A1;SLC25A11
prerank,insulin-like growth factor binding (GO:0005520),-0.4834517093480349,-1.2693935253933297,0.17165668662674652,0.529236109059878,1.0,4/15,5.13%,ITGA6;INSR;ITGB4;IGFBP6
prerank,carboxylic acid binding (GO:0031406),-0.3784751870983139,-1.26904543497195,0.11594202898550725,0.5245354860352908,1.0,15/38,18.59%,NOS3;GRM7;SRR;GLRB;GRIN2B;EPDR1;GCLC;PSAP;SESN3;GLRA2;THNSL2;GLUD1;CAD;GRIN1;UBR1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.274865819562482,-1.267560907668063,0.025236593059936908,0.5229711824560963,1.0,54/254,17.32%,MECOM;LEF1;MEF2C;ERG;ZBTB16;ELK3;ETS1;PLAGL1;TCF12;MEOX2;FOXO1;FOXO3;RUNX1;STAT3;NFATC1;PRDM16;PLSCR1;SIX1;NFIA;REL;JUN;ESR1;KLF7;SOX17;CREB3L1;SMAD1;ETV1;NRF1;ETV5;AR;ELF4;TFCP2L1;NFAT5;ELK1;IRF2;KLF4;RFXAP;HHEX;SOX18;FOXF2;FOSL2;MAFF;SOX12;TFCP2;NR4A2;ZNF445;ATF6B;FOXO4;NR1H4;ATF4;NFKB2;RREB1;FOXD2;SP7
prerank,pre-mRNA binding (GO:0036002),0.4383391649035074,1.2665080216444544,0.16698656429942418,0.7014043413919256,1.0,6/28,11.61%,CELF2;DDX5;HNRNPU;HNRNPL;PTBP1;SLBP
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5334463301374712,1.2664485412946636,0.21169354838709678,0.6933729865902309,1.0,4/11,9.99%,SLC25A42;SLC19A1;SLC25A25;SLC25A23
prerank,G protein-coupled receptor activity (GO:0004930),0.30252686956784725,1.2655963026172812,0.05697151424287856,0.6880055577762996,1.0,35/239,10.90%,TAS1R2;LGR4;GCGR;PTH2R;GPR135;GPR62;GPR143;NPR3;C5AR2;BDKRB1;OPRD1;ADGRG4;GPR87;CRHR1;ADRA2A;LPAR2;ADGRB2;ADGRB3;BDKRB2;GPR45;GPR12;GPR26;NTSR2;LPAR1;NMUR1;DRD3;ADGRV1;LTB4R2;GABBR1;C3AR1;ADGRL1;GPR37;ADGRG3;GABBR2;GRPR
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4346996030983994,-1.2626093052588419,0.15384615384615385,0.5303402092244397,1.0,5/20,9.35%,MAGI3;CASK;TJP2;MPP1;DTYMK
prerank,Hsp90 protein binding (GO:0051879),-0.3950732710431496,-1.2614099666557468,0.1403118040089087,0.5280989032773401,1.0,9/33,13.25%,SLC12A2;KDR;ERN1;RPS3;PTGES3;AHR;UNC45B;HDAC6;CSNK2A1
prerank,glutamate receptor activity (GO:0008066),0.4716692919193313,1.2612150298849898,0.19,0.693372453109337,1.0,6/19,16.59%,GRID2;GRIN2D;GRIK5;GRIK2;GRIA2;GRM8
prerank,calcium channel regulator activity (GO:0005246),-0.3829804183614423,-1.2582282046887483,0.1346578366445916,0.5305998294605274,1.0,5/37,4.52%,PRKG1;STIM2;YWHAE;STIMATE;SLC30A1
prerank,antiporter activity (GO:0015297),0.463748475077582,1.2572598176616172,0.18323586744639375,0.697866461301069,1.0,6/20,13.33%,SLC35E2B;SLC35E2A;SLC25A11;TMEM241;CLCN4;CLCN3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5119758733661051,-1.2556430213700152,0.20318725099601595,0.5313979198429105,1.0,3/11,9.26%,SGMS1;SGMS2;SAMD8
prerank,FAD binding (GO:0071949),0.4374662596569168,1.2535179733368282,0.18395303326810175,0.7015834958148552,1.0,9/24,15.32%,DDO;AIFM1;MICAL3;QSOX1;KMO;NDOR1;SQLE;CYB5R1;MTHFR
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2851983793111212,-1.2512791892383537,0.04722222222222222,0.5368130903252513,1.0,40/188,15.17%,MEF2C;PBX1;BNC2;ETS1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;TBX18;SIX1;JUN;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;XRCC5;ETV5;AR;KLF11;PRDM5;ELK1;AHR;KLF4;TAL1;MAFK;PER1;SOX7;HHEX;SOX18;LIN54;SOX12;SUV39H1;MTERF3;ARID5A;ATF6B
prerank,protein kinase C activity (GO:0004697),-0.4838149996126238,-1.250139106900962,0.19834710743801653,0.5340934818492198,1.0,5/14,7.90%,PRKCH;PRKD3;PRKD1;PRKCD;PRKCG
prerank,glucuronosyltransferase activity (GO:0015020),-0.4422146677298746,-1.2472453264662582,0.17184265010351968,0.5361088504240048,1.0,2/19,1.45%,CSGALNACT1;EXT1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4542881564620672,1.2467527409954757,0.1988071570576541,0.6993853409085067,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4542881564620672,1.2467527409954757,0.1988071570576541,0.6993853409085067,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,serotonin receptor activity (GO:0099589),0.4542881564620672,1.2467527409954757,0.1988071570576541,0.6993853409085067,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,ligand-gated cation channel activity (GO:0099094),0.34629440051058413,1.2445029656929785,0.14736842105263157,0.6990022898890147,1.0,15/75,15.09%,P2RX6;KCNJ13;KCNJ5;GRIN3A;GRIN2D;KCNJ10;GRIK5;GRIK2;KCNH2;CHRNB2;KCNJ16;TRPM2;SHROOM2;TRPM8;GRIA2
prerank,transmitter-gated ion channel activity (GO:0022824),0.4192124858921198,1.2419000044385007,0.20656370656370657,0.6995612003744509,1.0,8/29,15.09%,GABRG1;GRID2;GRIN2D;GRIK5;GRIK2;GABRG3;GABRB2;GRIA2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.31667901032841844,1.2403751328130495,0.08862876254180602,0.6969522713552886,1.0,21/134,9.99%,SLC6A13;SLC6A1;SLC22A6;SLC13A3;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC26A1;SLC38A1;MPC2;SFXN2;PDPN;SLC19A1;SLC25A25;SLC38A9;SLC25A12;SLC25A23
prerank,carboxypeptidase activity (GO:0004180),0.40110987079507043,1.2398429822115231,0.16135084427767354,0.6913361398662038,1.0,5/35,8.89%,AEBP1;CTSA;CPN1;AGBL4;CPA2
prerank,hexosyltransferase activity (GO:0016758),-0.3091263525594054,-1.2349306141572036,0.10552763819095477,0.561749426320674,1.0,31/101,24.08%,TMTC2;GCNT2;CSGALNACT1;EXT1;B3GNT2;B4GALT4;MTAP;TMTC1;GBE1;MGAT4A;B4GALT5;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;ALG6;POMT2;TMTC3;HAS2;ALG5;B3GNT3;DPY19L3;B3GALT5;B4GALNT3;B3GNT8;EXT2
prerank,histone acetyltransferase binding (GO:0035035),0.44759478493179716,1.2340026567984086,0.2019607843137255,0.7015958342212808,1.0,6/21,18.95%,EPAS1;PAX6;KANSL1L;STAT1;CITED2;MEF2A
prerank,protein phosphatase binding (GO:0019903),-0.29672532471218716,-1.233871411021433,0.08771929824561403,0.5592201941530242,1.0,24/117,10.09%,DAB2IP;MAP3K5;FOXO1;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;MFHAS1;ANAPC5;STRN3;RACK1;MET;PPP1R16B;PXN;KCNQ1;SHOC2;CEACAM1;SOD1;FLT4;EIF2AK3;JAK1;GTF2F1
prerank,peptidase inhibitor activity (GO:0030414),0.40452408468889267,1.232292824991377,0.19397363465160075,0.6998209374368599,1.0,6/33,11.05%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2
prerank,filamin binding (GO:0031005),0.5376186226673499,1.232254055628447,0.2286282306163022,0.6928815496489398,1.0,4/11,11.10%,NEBL;RFLNA;CRMP1;TMEM67
prerank,mRNA 5'-UTR binding (GO:0048027),-0.40931902397977776,-1.2304086611074878,0.206,0.5626513947400015,1.0,12/24,29.66%,RPL41;RPL5;GNL3;RPS7;SYNCRIP;FMR1;RPS13;NCL;SHMT2;SHMT1;IGF2BP2;IGF2BP1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.45726632397168293,1.229039893360913,0.21499013806706113,0.6951349339439087,1.0,4/17,7.15%,GRIN3A;GRIN2D;GRIK5;GRIK2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4590369491253661,-1.2256652939096198,0.2222222222222222,0.5641558428769896,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.4590369491253661,-1.2256652939096198,0.2222222222222222,0.5641558428769896,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,sterol transfer activity (GO:0120015),-0.4532509748177901,-1.225530662560903,0.21868365180467092,0.5592614427455064,1.0,7/17,11.77%,ABCA1;PLTP;NPC2;OSBP;MTTP;STARD4;GRAMD1A
prerank,amino acid transmembrane transporter activity (GO:0015171),0.3745702297003465,1.2251758801299244,0.16666666666666666,0.6996970803855838,1.0,8/47,6.78%,SLC6A13;SLC6A1;SLC38A3;SLC7A11;SLC25A44;SLC38A1;SLC7A13;PDPN
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5072203356029155,-1.2220817216329254,0.2283464566929134,0.5627061682727822,1.0,3/11,8.83%,LEF1;ZXDC;GATA2
prerank,rRNA binding (GO:0019843),-0.3598914937908643,-1.2214761687445426,0.16452991452991453,0.5590685019607664,1.0,12/42,17.03%,RPL5;RPLP0;RPS5;RPS3;RPL23;RPS9;NGRN;RPL12;CAVIN1;RPS13;GTF3A;PTCD3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5076580627856002,-1.2193859321170384,0.2155688622754491,0.5594963778298575,1.0,7/10,31.29%,ANKRD13A;DNAJC2;ANKRD13B;USP15;ANKRD13D;FAAP20;LAPTM5
prerank,metalloexopeptidase activity (GO:0008235),0.3607891471243976,1.219114095302981,0.18421052631578946,0.7112670694171227,1.0,4/51,2.65%,AEBP1;METAP2;CPQ;CPN1
prerank,calcium-release channel activity (GO:0015278),0.4658528904302103,1.2175232466173422,0.24675324675324675,0.7091109940834591,1.0,5/17,11.47%,TRPV1;ITPR1;ITPR2;RYR2;TRPM2
prerank,N-methyltransferase activity (GO:0008170),0.44935155391720066,1.216838323393937,0.21453900709219859,0.7045970834770054,1.0,7/20,17.09%,FDXACB1;N6AMT1;RNMT;TRMT11;METTL5;METTL18;TRMT1L
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4856696218479317,-1.2160580168910595,0.2210953346855984,0.5633275305029378,1.0,2/13,3.62%,SLC9A2;SLC9B2
prerank,mRNA 3'-UTR binding (GO:0003730),0.3381722451305473,1.2151596709707508,0.14358108108108109,0.7029307159672536,1.0,25/79,20.69%,CPEB2;CELF2;DDX5;ANGEL2;ELAVL4;HNRNPA2B1;PABPC4L;HNRNPU;EXOSC8;CPEB4;UTP23;ELAVL1;RNF20;BOLL;FXR2;CSDC2;PCBP4;ELAVL2;CCT5;RNPS1;CPEB3;LARP4B;ILF3;ELAVL3;LARP1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.38186546054654014,-1.2145305658481997,0.18237704918032788,0.562154646303534,1.0,7/30,13.08%,SLC39A10;SLC40A1;SLC30A1;SLC39A8;SLC31A1;SLC39A7;SLC30A5
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.48721846711102085,1.2135021316763774,0.24947589098532494,0.7011376135270933,1.0,2/14,1.22%,ADH7;ADH4
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.48933357127242644,-1.2108794315456075,0.22560975609756098,0.5663943641701497,1.0,2/12,3.62%,SLC9A2;SLC9B2
prerank,N-acyltransferase activity (GO:0016410),0.4003579443429539,1.210828074926371,0.2208029197080292,0.7027977205693172,1.0,5/32,6.88%,NMT2;GNPNAT1;PLAAT5;SAT1;GLYAT
prerank,cholesterol binding (GO:0015485),0.37041068852657655,1.2101098865576796,0.1978984238178634,0.6985003159178398,1.0,10/47,9.10%,OSBPL8;ANXA6;SOAT2;SIDT1;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.37312755155521027,1.2094005749075771,0.2072072072072072,0.6940826984924865,1.0,3/48,0.80%,TRPM3;SLC41A1;TRPM6
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2594521165878877,-1.208436899521205,0.04391891891891892,0.5674062746607955,1.0,107/335,23.11%,PRKCH;SNRK;BMPR2;MARK1;NEK7;ACVR1;HIPK1;ACVRL1;MAP3K5;RPS6KA5;STK38L;STK3;EGFR;LIMK2;BCR;AKT3;ALPK1;TGFBR2;IRAK3;CDK14;RPS6KA3;TNIK;PRKD3;BRD4;NUAK1;CASK;CPNE3;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;CIT;ERN1;CDC42BPA;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;CSNK1G3;PRKCG;RPS6KA2;STK24;CDK5;MAP4K4;EIF2AK3;STK33;MAPKAPK2;NEK3;BCKDK;VRK3;SQSTM1;GRK5;STK10;DYRK1A;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;IRAK2;PKN3;LIMK1;PRKACA;MKNK2;TAOK3;MAST2;MAP3K8;LATS1;MASTL;TAOK1;HUNK;STK35;MAPK12;CDK16;CDK6;MAPK3;CAMK1G;MARK3;STK17B;RIPK1;TRIO;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;MYLK;SYK;ROCK1;TOP1;RIPK2;CDKL4;MAP3K4;SLK;SIK3;MAP4K3;MAPK11;CDK11B;GAK;STK32C
prerank,chemokine receptor binding (GO:0042379),-0.37677324053976013,-1.208325014920399,0.20217391304347826,0.5629002273821383,1.0,24/35,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CX3CR1;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,growth factor receptor binding (GO:0070851),-0.30677572020227484,-1.2040496325568193,0.12106537530266344,0.5688745357724198,1.0,20/95,14.74%,HIP1;IL6ST;IL1R1;VEGFC;ITGA5;PTPRJ;PLSCR1;ERN1;SNX1;IL6R;IL1RAP;SRC;PDGFC;FGF2;FGF7;ESM1;PIBF1;PDGFD;VEGFA;SNX2
prerank,myosin V binding (GO:0031489),-0.4528209600885643,-1.2036114798401032,0.22199170124481327,0.565379554674161,1.0,8/15,23.02%,RAB14;RAB6A;RAB3A;RAB11B;RAB11A;RAB3D;RAB27B;RAB3B
prerank,retinoic acid receptor binding (GO:0042974),-0.4378159609665516,-1.2003119383109055,0.2217741935483871,0.569473798826757,1.0,7/17,14.83%,ACTN4;TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3699827589521788,-1.2001513549295646,0.19583333333333333,0.5650753233069504,1.0,10/32,14.08%,SLC6A6;SLC1A5;SLC7A5;SFXN1;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.41900137248741876,-1.1967508991752112,0.21413721413721415,0.5688860904020668,1.0,5/20,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.48237115291588506,-1.1957565393843737,0.22700587084148727,0.5668380867113034,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.4090953331422984,1.1946853465998126,0.23597678916827852,0.7314199103486084,1.0,6/28,13.92%,GABRG1;GRID2;GRIK5;GRIK2;CHRNB2;GABRG3
prerank,"DNA binding, bending (GO:0008301)",-0.4712219810468588,-1.1946741442445419,0.23721881390593047,0.5648977266712822,1.0,4/14,20.34%,LEF1;HHEX;TOP2A;HMGB1
prerank,phosphatidic acid binding (GO:0070300),-0.4233109109123445,-1.1934674106893592,0.2053388090349076,0.5631361492393218,1.0,6/19,10.77%,PITPNC1;RAPGEF2;MARK1;PLTP;RAPGEF6;JPH2
prerank,phosphatase inhibitor activity (GO:0019212),-0.4149802936763506,-1.1918781437967467,0.20689655172413793,0.561979855248799,1.0,9/20,31.30%,PTN;MGAT5;PPP1R2;BOD1L1;SET;TESC;PPP1R1B;LMTK2;ANP32E
prerank,chemokine activity (GO:0008009),-0.3782158769006909,-1.1905210228573282,0.21428571428571427,0.5606322606310062,1.0,22/31,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,clathrin adaptor activity (GO:0035615),-0.4517265258963938,-1.189977588074301,0.24628450106157113,0.5576418585573019,1.0,6/15,16.64%,HIP1;STON2;AP2B1;HIP1R;AP2A1;LDLRAP1
prerank,copper ion binding (GO:0005507),0.3706470986544796,1.1886791782619628,0.20696324951644102,0.7430632606226788,1.0,14/42,22.11%,MOXD1;LOXL3;SUMF1;LACC1;CUTC;RNF7;ATP7A;IL1A;PRNP;P2RX4;AOC2;PAM;ATP13A2;COA6
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5213915117864355,1.187096860916968,0.2745490981963928,0.7413601312368605,1.0,2/10,3.91%,TRPV1;GABRG1
prerank,steroid hydroxylase activity (GO:0008395),-0.4405208981918213,-1.1845329765375066,0.23847695390781562,0.5668030830187023,1.0,3/16,5.23%,CYP7B1;CYP1B1;CYP39A1
prerank,channel activity (GO:0015267),0.37158699485014396,1.1827105385906016,0.22434782608695653,0.7485199605671624,1.0,6/41,10.41%,P2RX6;TRPV1;TMEM120B;PDPN;MPV17;BCL2
prerank,E-box binding (GO:0070888),-0.362177055264659,-1.1820147089159352,0.20474137931034483,0.5687101472569703,1.0,8/34,11.58%,ZEB1;BHLHE40;HES1;AHR;TAL1;PER1;SREBF2;TWIST1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4135525122150878,1.1813755934213859,0.23865877712031558,0.7460894205587173,1.0,3/27,2.74%,SLC8A3;SLC41A1;SLC23A1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4928523167785668,1.1805710810374688,0.2757936507936508,0.7419344360519924,1.0,2/12,1.69%,ADH4;NQO1
prerank,protein heterodimerization activity (GO:0046982),0.2883393236053608,1.1801479649497038,0.13099041533546327,0.7367117740752314,1.0,36/178,14.90%,ATP1A2;EPAS1;BMP6;NPAS3;ABCG5;TOP2B;RRAGC;MIGA2;ARNT2;TENM1;PGLYRP3;SIM1;CHUK;ZHX1;ATP1B2;ADRA2A;ADD2;BDKRB2;ADCY8;IKBKG;FZD9;LSM5;PAFAH1B2;BCL2;GABBR2;USF1;TAF1;BHLHE41;QTRT2;MICU1;CYBA;ARNT;QTRT1;FXR2;DGKD;SMC3
prerank,ligand-gated calcium channel activity (GO:0099604),0.44114319556211556,1.1796481138585408,0.2606177606177606,0.7318397085158348,1.0,6/19,13.91%,TRPV1;ITPR1;GRIN2D;RYR2;TRPM2;TRPM8
prerank,signal sequence binding (GO:0005048),-0.36452319406596356,-1.1794352231600422,0.2141280353200883,0.5703065132251189,1.0,10/35,15.22%,NFKBIA;AP2B1;TIMM22;CAT;BABAM2;IPO5;KDELR3;CEMIP;SEC61A1;KPNA2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.45925452568304914,-1.1777326915562787,0.26705653021442494,0.5702032409354796,1.0,8/13,32.05%,SH3BP4;ARHGDIB;ARHGDIA;RANBP1;GPSM2;GDI1;ITGB1BP1;GDI2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3847312340009503,-1.176740648943652,0.24696356275303644,0.5681387714050811,1.0,8/24,10.77%,PLA2G4A;DAB2IP;CERT1;PLEKHA8;OSBP;GOLPH3;PLEKHA5;JPH2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3570132631647834,-1.1765215325411644,0.21300448430493274,0.5643865191496232,1.0,13/35,24.52%,PEAK1;BMX;TEC;LYN;SRC;YES1;DYRK1A;PTK2B;BTK;HCK;SYK;FYN;FES
prerank,syntaxin-1 binding (GO:0017075),0.41923195696009014,1.1752494133603333,0.2585278276481149,0.7387768367958784,1.0,11/22,24.17%,UNC13C;SYT1;LRRK2;SNAP25;NSF;CPLX1;CPLX2;STXBP3;SYNPR;SNPH;STXBP2
prerank,ATP hydrolysis activity (GO:0140603),0.3633524298655575,1.1752119988415808,0.22021660649819494,0.7327261002114412,1.0,11/41,11.47%,HSPA1A;ABCA4;RUVBL2;TDRD9;ABCB10;ATAD1;CHD3;TOR1B;ABCD1;MYO18A;CLU
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.359838957984912,-1.1736301091771386,0.21473684210526317,0.5673398807550247,1.0,4/35,1.79%,PLCB4;PLCE1;GPCPD1;PLCL1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.38080079494711916,-1.1730715463490171,0.2346723044397463,0.5644167931462689,1.0,4/25,2.70%,FMO1;MICAL2;NOS3;FMO2
prerank,protein kinase binding (GO:0019901),-0.241426430290109,-1.1727394582861912,0.038314176245210725,0.5610735074607593,1.0,90/480,13.98%,UTRN;ACTB;LIMS1;GHR;FRMD5;CAV1;PDLIM5;SLC12A7;SLC12A2;BMPR2;DAB2IP;PTN;RHOBTB1;RHOA;ACVR1;ACVRL1;PKD1;IQGAP1;FOXO3;BCL2L1;CAVIN2;PLCG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;ESR1;CACUL1;PLCG2;ADCY4;GCH1;ITGB1;SPRED2;TFRC;TJP2;SMAD1;PAK2;CIT;RACK1;ADAM10;EEF2;TRIM14;PRKCD;KCNQ1;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;NBR1;EMP2;CEACAM1;ACTA2;HDAC7;HDAC9;PTPN1;MAPKAPK2;BCAR1;CIR1;NEDD9;RPTOR;DUSP3;YWHAZ;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GRK5;GSKIP;TPR;ROR2;RND3;TRPV4;STK38;PEBP1;PTPRC;CD24;IRS1;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,hyaluronic acid binding (GO:0005540),-0.4902419113055668,-1.1718155944818207,0.2721774193548387,0.5591436077344814,1.0,3/10,11.98%,LAYN;CD44;CEMIP
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3214930338252473,1.1701112085023035,0.20458553791887124,0.7418497452352543,1.0,14/85,12.53%,CEL;LIPA;ASPG;PON1;PLAAT5;PLA2G4C;DDHD2;ABHD5;TARS2;MRPL58;PAFAH1B2;PLA2G15;ABHD3;GDE1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2515059489625107,-1.168336807128006,0.08,0.5636101959556704,1.0,89/254,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;SLC22A18;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO2;CASP8
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.48402421852133315,-1.167768789597283,0.2578740157480315,0.5608565340946264,1.0,3/12,10.41%,TRAF5;TRIM37;BABAM2
prerank,DNA replication origin binding (GO:0003688),-0.39952671588701644,-1.166685002706728,0.23705179282868527,0.5591945145781555,1.0,12/23,32.32%,KAT7;ORC1;ORC2;CDC45;ORC5;POLA1;MCM3;MCM5;MCM6;GRWD1;ORC3;CDC6
prerank,phosphatase activity (GO:0016791),0.3276997819744625,1.166102276860012,0.23195876288659795,0.7475458782205504,1.0,14/73,15.10%,ATP1A2;PON1;LPIN1;DUSP11;PXYLP1;PRUNE1;ARMT1;PLPPR3;ACP6;CILP2;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4505960126251221,1.1659243419650294,0.2859848484848485,0.7419035051871948,1.0,8/16,25.04%,SLC13A3;SLC25A11;SLC25A12;SLC38A7;SLC25A13;SLC13A5;SLC25A18;SLC1A4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.3864135303528907,-1.1645272991122158,0.2587991718426501,0.5604528018690247,1.0,3/25,6.75%,HIP1;ARAP3;PLEKHA4
prerank,GTPase activity (GO:0003924),-0.265351284600266,-1.1620567207469723,0.11988304093567251,0.5623874072426481,1.0,59/192,21.10%,RHOJ;DNM3;RHOBTB1;RHOA;RAB14;RAP1A;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;GNB1;ARHGDIB;EEF2;RASL12;NKIRAS1;BMS1;GFM1;RAB22A;DNAJC27;GNG5;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;RAP2B;GNL1;MRAS;SRPRA;RHOBTB3;RAB11A;GNA14;ARL8B;CDC42;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,ATPase binding (GO:0051117),-0.3091846773705664,-1.159286357631977,0.18660287081339713,0.5649415120834912,1.0,17/71,9.94%,PDE4D;CAV1;SLC2A13;EGFR;ABCA1;ATP6V0A4;ESR1;RALB;NKD2;GABARAPL2;AR;CHMP4A;PPP3CA;UBXN1;SRC;ATP6V0A1;TRPC1
prerank,platelet-derived growth factor binding (GO:0048407),0.496449483399959,1.1575659620311283,0.305668016194332,0.7614026035452073,1.0,3/11,5.94%,COL5A1;PDGFRA;COL1A2
prerank,Toll-like receptor binding (GO:0035325),-0.4764116723202399,-1.1574656424012968,0.274582560296846,0.5655198311654103,1.0,7/11,34.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4811885864254259,-1.156730138579428,0.2907216494845361,0.5633574354651256,1.0,5/11,13.43%,TRPC3;TRPC6;TRPC4;TRPC1;ITPR3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.3065352947652977,-1.1537862594977335,0.1864801864801865,0.5667222930630185,1.0,27/70,29.96%,GCNT2;CSGALNACT1;EXT1;B3GNT2;MGAT4A;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;HAS2;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;EXT2;GCNT4;RFNG;POGLUT1;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,histone deacetylase binding (GO:0042826),-0.297133985926352,-1.1531918593226649,0.19174757281553398,0.5642079066113357,1.0,27/88,19.85%,LEF1;MEF2C;YWHAE;MIER1;GLI3;YWHAB;NIPBL;HES1;ANKRA2;NACC2;HDAC9;RBBP4;HEY2;CIR1;TAL1;MTA1;NACC1;HDAC6;SP2;KPNA2;TOP2A;HDAC2;MIER2;MTA3;CCND1;PRDM1;SPI1
prerank,tRNA methyltransferase activity (GO:0008175),-0.4172397081120215,-1.1501089301000922,0.26706827309236947,0.5678442010868037,1.0,7/16,19.64%,METTL2B;METTL2A;THUMPD2;FTSJ1;TRMT44;TYW3;LCMT2
prerank,phosphatidylinositol binding (GO:0035091),-0.2869282677839609,-1.147507570612202,0.2135678391959799,0.5701974630783249,1.0,22/91,17.43%,HIP1;PITPNC1;ESYT2;PARD3;SCARB1;MCF2L;ANKFY1;SNX13;FCHO2;TNFAIP8L3;SNX1;ZFYVE16;ESYT3;AIDA;SNX10;HIP1R;ITPR3;SNX2;PITPNB;PIGK;EPB41;DENND1B
prerank,GABA receptor binding (GO:0050811),0.4868290459648715,1.1470463382873126,0.3060796645702306,0.7872445417338082,1.0,3/11,8.63%,TRAK1;SHISA7;JAKMIP1
prerank,RNA polymerase binding (GO:0070063),0.4361096103128286,1.1465660035516583,0.28600823045267487,0.7823747084179862,1.0,5/18,13.51%,PABPN1;CCNT2;TAF10;TCERG1L;YTHDC2
prerank,transaminase activity (GO:0008483),0.4789868291515181,1.1456755479854848,0.32061068702290074,0.7788815493231953,1.0,6/11,27.07%,BCAT2;GOT1;GOT2;BCAT1;PSAT1;ABAT
prerank,cytokine activity (GO:0005125),0.2919438277856437,1.1454816486946198,0.20741989881956155,0.7733466001615482,1.0,12/131,7.55%,BMP7;BMP6;WNT4;IL18;WNT5B;WNT7A;IL17D;BMP3;BMP8A;WNT6;NRG1;INHA
prerank,protein homodimerization activity (GO:0042803),-0.2310180775054419,-1.14517916623155,0.045283018867924525,0.5718961905598133,1.0,122/590,15.39%,HIP1;ABCG2;SYNE1;GHR;ACTN4;PECAM1;ECE1;DAB2IP;ZBTB16;SLIT2;LRRFIP1;EXT1;LRP6;ANO1;FOXP2;B2M;ACVR1;FAP;TGFB2;PIP4K2A;MAP3K5;RBPMS;MYH9;BCL2L1;ZHX3;STAT3;MID1;RASIP1;TBX18;IRAK3;MKLN1;F11R;NOD1;MFF;MID2;TBX1;DEFA6;ACTN1;SCARB2;FLNA;GBP4;PANK3;BHLHE40;ACOX1;GCH1;TFRC;GSS;CISD2;MGLL;TPD52;TRIM37;CAMK2D;GBP5;XDH;S100A13;NECTIN3;ERN1;RACK1;HES1;TPM4;ADAM10;SNX1;TRPC6;PDE2A;NRF1;TRIM14;IL6R;SRR;CHMP4B;CHMP4A;DPY30;NACC2;ZBTB1;SPPL3;CEACAM1;TPM2;ABCD2;PEX7;CUBN;AOX1;PDGFC;FLT4;FBXO4;CAT;AHR;APOE;S100A6;S100A11;DROSHA;CAV2;MFSD1;PSAP;DSCAML1;YARS2;S100A16;HSPB1;STK10;FZD4;ASMT;PHB2;HHEX;TPST2;BLM;HIP1R;TPR;RRAGA;RPE;SMCHD1;NFS1;ENPP1;VEGFA;HOGA1;CIP2A;HM13;ZNF318;SNX2;IRAK2;S100A10;VAPB;NQO2;BAK1;RAP1GAP
prerank,ion channel inhibitor activity (GO:0008200),-0.34884947147376466,-1.140248974405643,0.25054945054945055,0.580065513263516,1.0,10/35,16.14%,NEDD4L;STX1A;SLC30A1;CAMK2D;RACK1;KCNMB2;MCUB;STX7;STX8;CFTR
prerank,low-density lipoprotein particle binding (GO:0030169),-0.41687296539918106,-1.1395694200768745,0.29321663019693656,0.5777265294239198,1.0,5/16,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,protein kinase regulator activity (GO:0019887),0.3062289812740548,1.1390102738974808,0.2193126022913257,0.787130454229686,1.0,8/95,4.22%,PRKAG2;SH3BP5L;PRKAG3;GPRC5A;GPRC5C;GPRC5B;CCNT2;SH3BP5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.43499545819026425,-1.1388949249709743,0.2762096774193548,0.5753185109323385,1.0,6/14,23.56%,OTUD7B;MINDY1;USP7;MINDY2;USP15;ATXN3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.34565071573128703,1.138175660504588,0.24783362218370883,0.7834293628014805,1.0,7/51,6.17%,SLC22A6;SLC22A8;SLC5A5;SLC35E2B;SLC35E2A;SLC25A11;TMEM241
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.42221385830535085,1.1353407692778787,0.28488372093023256,0.7862263313132416,1.0,4/19,7.15%,GABRG1;GRID2;GRIK5;GRIK2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2263109819210361,-1.1353146415963626,0.043478260869565216,0.5798163804510781,1.0,148/730,17.32%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TWIST1;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3559100226072527,-1.134949011268975,0.27415730337078653,0.5768228944332655,1.0,10/29,25.31%,PTPRJ;NFATC1;GCH1;NBR1;MAPKAPK2;TPR;DUSP6;DUSP1;PRMT1;DUSP7
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.45925267533294206,1.1346752889556848,0.29880478087649404,0.7823251387986595,1.0,6/14,22.61%,AIFM1;NOX1;KMO;CYBA;NCF1;MICAL1
prerank,lipoprotein particle binding (GO:0071813),-0.39251471620789885,-1.1328712139892863,0.28348214285714285,0.5777690348987216,1.0,5/20,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,dynactin binding (GO:0034452),0.4831793606164608,1.132318903579043,0.3405940594059406,0.783915027439085,1.0,3/12,9.94%,SNX6;HTT;BICD1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.22539372454305462,-1.1317875255232752,0.06372549019607843,0.5770334880063622,1.0,152/731,18.02%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;FOXN3;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7;MKX;FOXN2;JUNB;ZBTB37;PRRX1
prerank,diacylglycerol kinase activity (GO:0004143),-0.469330994482059,-1.1295207099657198,0.3158995815899582,0.5784678976271798,1.0,3/11,3.98%,DGKH;DGKZ;AGK
prerank,G protein-coupled receptor binding (GO:0001664),0.2887280830373878,1.1285711884163863,0.23208722741433022,0.7902937226325512,1.0,22/132,14.28%,RNF43;WNT4;HSPA1A;WNT5B;TULP3;WNT7A;GPRC5B;ARR3;NTS;GPRASP2;WNT6;ARRB1;ARHGEF11;FZD7;RSPO1;C1QBP;BICD1;USP20;GRK3;GNAO1;PSMC5;HSPA1B
prerank,MAP kinase kinase activity (GO:0004708),0.4333936005797306,1.128321062236247,0.30592734225621415,0.7851173122744496,1.0,4/15,10.91%,MAP2K6;LRRK2;MAPK10;MAPK14
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.43314506401085096,-1.1281996129689407,0.31274900398406374,0.5782484115400518,1.0,5/15,16.14%,SLC26A7;SLC26A2;SLC39A8;SLC26A6;CFTR
prerank,kinase activity (GO:0016301),0.2984378555008653,1.1256325133268041,0.24918032786885247,0.7875278742252847,1.0,27/109,17.57%,NADK2;SPHK1;GK;TKFC;PANK1;STK39;PSTK;PIK3CB;COQ8B;PGK1;PANK2;LRRK2;DGKI;CHKB;TAF1;EPHA4;PI4KA;SPHK2;DGKE;DGKD;IPPK;ABL1;CERK;CDKL5;PKMYT1;IP6K2;CDK5R1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4871297761189438,1.1232689334445927,0.336,0.7888006818387324,1.0,4/10,19.30%,ECHDC3;ECHS1;ECHDC2;HSD17B4
prerank,double-stranded DNA binding (GO:0003690),-0.22886539575992462,-1.120275359624203,0.1134453781512605,0.5930052337468485,1.0,125/531,21.40%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;RARB;TBX15;TCF12;MEOX2;PPARD;FLI1;RAD51B;TBX3;EGFR;RUNX2;FOXO3;POLR3F;NFATC1;TBX18;SIX1;CRY1;GLI3;JUN;ESR1;TBX1;NFIX;TFEB;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;LHX6;AIM2;HES1;ETV1;NR3C2;JDP2;XRCC5;REXO4;SP3;ETV5;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;MBNL2;RPS3;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;HOXA6;ETS2;CPSF4;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;SOX18;DMC1;KIN;RARG;TBX2;MAFF;SOX12;HSF5;KLF2;TFCP2;NR4A2;ZNF445;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;TDG;FOXN2;JUNB;NEIL3;ZBTB37;NR2F1;ZCCHC3;HIVEP1;FOXE1;PRDM1;IRF5;SOX8;ZNF177;PAX3;RAD51AP2;HOXA4;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3;HSF4;ZBP1;CENPX;ZBTB45;JUND;MAU2;TOP1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.23898130429920447,-1.1179246638828226,0.13312693498452013,0.5951467203639809,1.0,92/269,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;SLC22A18;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;HGS;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;DTX3L;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO3;SUMO2;CASP8
prerank,chloride channel activity (GO:0005254),-0.3023136835774599,-1.1167580660122354,0.2516703786191537,0.5942011715565144,1.0,13/59,16.14%,SLC26A7;CLIC4;ANO1;TTYH2;CLIC1;GABRA3;GLRB;CLCC1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,R-SMAD binding (GO:0070412),0.42094543645835814,1.1164541371858605,0.34911242603550297,0.80413629227336,1.0,8/18,21.84%,DDX5;SMAD3;PAX6;MEN1;PMEPA1;SMAD4;SMAD2;TRIM33
prerank,potassium channel regulator activity (GO:0015459),0.3378119420950725,1.1150943179932413,0.3072916666666667,0.8023257779454087,1.0,10/49,14.30%,KCNIP3;LRRC38;SLC5A3;WNK3;DLG1;WNK4;DPP10;KCNIP4;ENSA;KCNS3
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.28881102037527046,-1.1143600417810973,0.23058823529411765,0.5959288176415132,1.0,14/71,12.01%,PTPRM;PTPRB;PTPRG;PTPN12;PTP4A2;PTPRJ;PALD1;PTPRK;UBASH3B;PTPN1;DUSP3;PTP4A3;PTPRZ1;DUSP23
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3862569962444539,1.1087546046515793,0.3225225225225225,0.8158817587807918,1.0,1/26,0.05%,PPP1R1A
prerank,estrogen receptor binding (GO:0030331),-0.34815140287783514,-1.1075594018386126,0.30425531914893617,0.6086876878264159,1.0,11/32,14.83%,LEF1;TACC1;WIPI1;ESR1;NRIP1;DDX54;PHB2;DCAF13;RERG;NCOA6;ARID5A
prerank,transcription coregulator binding (GO:0001221),0.3348503690293816,1.1071104932928149,0.2928082191780822,0.815358770648767,1.0,16/50,17.96%,RORA;SMAD3;THRB;CCNT2;USP11;PHF1;MED25;LCOR;ZBTB49;TERT;CTBP2;PER2;CHD6;RELA;MTF2;HDGF
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2398950035660067,-1.1063745467906252,0.19197707736389685,0.6078927833076573,1.0,74/248,21.10%,RHOJ;DNM3;RHOBTB1;RHOA;ATP2B1;RAB14;RAP1A;MYH9;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;MYL6;GNB1;ARHGDIB;EEF2;ABCA3;RASL12;ABCD2;NKIRAS1;BMS1;CHD1L;GFM1;MYO19;RAB22A;DNAJC27;GNG5;DYNC1I1;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;SMCHD1;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;KIF1C;RAP2B;CFTR;GNL1;RUVBL1;MRAS;SRPRA;KIF20B;RHOBTB3;RAB11A;GNA14;ARL8B;ABCG4;CDC42;GPR88;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,cytokine receptor binding (GO:0005126),-0.28250082907491547,-1.1058218699213085,0.2853598014888337,0.6054916201564785,1.0,13/83,10.02%,KITLG;IL6ST;OSMR;LIFR;TGFB2;VEGFC;SOCS2;SPRED2;CXCL12;IL6R;IL34;IL1RAP;JAK1
prerank,histone acetyltransferase activity (GO:0004402),0.37178590055949784,1.1036467094493128,0.3103448275862069,0.8203271573638309,1.0,11/30,19.95%,MCM3AP;KAT5;ARRB1;TAF10;CLOCK;KAT14;TAF1;BAZ1A;TADA3;KAT6B;KAT8
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4139532111699198,1.1024615991715507,0.3488372093023256,0.8182799836848821,1.0,2/18,9.08%,HSD17B2;DHRS11
prerank,cholesterol transfer activity (GO:0120020),-0.4152651580622952,-1.1008909359988415,0.3382978723404255,0.6134132397498194,1.0,6/16,11.77%,ABCA1;PLTP;NPC2;MTTP;STARD4;GRAMD1A
prerank,ephrin receptor binding (GO:0046875),-0.38044197184154965,-1.0979151715619482,0.31556503198294245,0.6166745212440934,1.0,6/21,8.95%,ANKS1A;CHN1;LYN;EFNA5;SRC;PTPN1
prerank,ATP binding (GO:0005524),0.26003591364200923,1.0977477656057169,0.26362297496318116,0.8273173530115064,1.0,37/266,12.43%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;PRKCI;KSR1;MSH6;ABCD1;OAS3;TGFBR1;MYO18A;PEX1;MTHFS;DARS2;RTEL1;SYN3;PYGL
prerank,endopeptidase regulator activity (GO:0061135),0.35152697917310866,1.0969623508697637,0.3412844036697248,0.8238939441715248,1.0,8/40,13.27%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2;APH1A;ABCA2
prerank,nuclear export signal receptor activity (GO:0005049),-0.4463034272004709,-1.0963079891118839,0.35019455252918286,0.6170415359038659,1.0,7/11,36.05%,XPO5;XPO6;NUP214;XPO7;NUP42;RAN;XPO1
prerank,semaphorin receptor activity (GO:0017154),-0.4520180430531069,-1.096299324260997,0.3210633946830266,0.6134238329628102,1.0,2/11,0.78%,NRP1;NRP2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.43014300789607274,1.0929384429897906,0.3562386980108499,0.8309382370635444,1.0,3/14,8.02%,KCND3;KCNJ5;KCNH2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3046216727670081,-1.091723040132607,0.3,0.6205552515057069,1.0,13/53,14.08%,SLC47A1;SLC1A5;SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,voltage-gated ion channel activity (GO:0005244),0.43426273690245437,1.0911617666712499,0.3530571992110454,0.8307456879141437,1.0,6/14,24.42%,KCNA3;KCND2;VDAC1;VDAC2;VDAC3;HCN1
prerank,histone methyltransferase activity (GO:0042054),0.36240859757317156,1.0899145465623865,0.33707865168539325,0.8289656451872031,1.0,9/32,15.21%,KMT5A;DOT1L;PRMT2;N6AMT1;SETD7;SMYD3;SMYD2;MEN1;NTMT1
prerank,zinc ion binding (GO:0008270),-0.2361874655148414,-1.0896518096267926,0.20754716981132076,0.6219742982168783,1.0,66/293,15.19%,LIMS1;MSRB3;SHANK3;MYRIP;ECE1;ZEB1;CBLB;TNFSF10;CTCF;PLSCR1;ENPEP;KLF7;KAT6A;ZDHHC20;GCH1;ADH5;ARHGEF2;CRIP1;RNF125;TNKS;SEC24D;S100A13;MSRB2;ZNF3;CRIP2;HHIP;PDE2A;PAPPA;ARIH2;GRIN2B;HPF1;ZFPM2;SEC23A;SOD1;PTPN1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ADH1A;ARIH1;KLF4;RABIF;RPS29;SIRT5;TES;RPS27;PTGR2;BLM;ACE2;SLC30A5;LNPEP;ENPP1;SEC24B;LANCL1;CLIP1;SMPDL3A;IFIH1;MT3;CA2;ADAM33;NQO2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.43678693005871094,-1.0892370744576634,0.3727087576374745,0.6157886336612935,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),-0.43678693005871094,-1.0892370744576634,0.3727087576374745,0.6157886336612935,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,pentosyltransferase activity (GO:0016763),0.34822921877457225,1.086778907690834,0.3178294573643411,0.8327674376140144,1.0,16/36,24.24%,LARGE1;TNKS2;LACC1;PARP14;PARP4;UPP2;PARP16;QTRT2;QTRT1;SIRT1;UMPS;ART4;PARP10;QPRT;PNP;TIPARP
prerank,neuropeptide receptor activity (GO:0008188),0.3698245471183023,1.0854976145724278,0.3291592128801431,0.8313353025963524,1.0,5/29,13.54%,GPR143;NMUR1;GPR37;GRPR;OPRM1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.34536300928627317,1.0853322390901992,0.3333333333333333,0.8262599030389027,1.0,8/38,14.45%,TFPI;SERPINA10;FURIN;SERPIND1;HRG;SPINT2;SERPINA9;SERPINE3
prerank,double-stranded RNA binding (GO:0003725),-0.2871989764455826,-1.084326612996901,0.2935064935064935,0.6237711648009806,1.0,22/70,23.33%,MBNL1;RFTN1;LRRFIP1;AGO1;ADARB1;ACTN1;DHX33;TFRC;SIDT2;AGO2;DROSHA;IFIH1;FMR1;FXR1;AGO4;MRPL44;ZBP1;MSN;EIF4H;PRKRIP1;ZFR;TARBP2
prerank,protease binding (GO:0002020),-0.2704496143733762,-1.0825003261677388,0.286783042394015,0.6247240445040955,1.0,18/99,12.62%,VWF;SLC2A13;FAP;F3;FN1;UBC;CARD16;ITGB1;CRADD;CST3;CCBE1;SERPINE1;SPATA2;PSAP;COL1A1;SERPINB9;COMP;ECM1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3285745506885772,1.0820533936613066,0.3339222614840989,0.8304808893693684,1.0,9/55,11.47%,CACNA1D;ANXA6;SLC24A3;TRPV1;ITPR1;PKD2L2;ITPR2;RYR2;TRPM2
prerank,metal ion binding (GO:0046872),-0.22298267677874462,-1.0808756525029373,0.16216216216216217,0.6252987834784722,1.0,120/477,21.27%,CDH11;SNRK;SPARC;LTBP4;SPOCK2;RAPGEF2;PLA2G4A;ESYT2;CSGALNACT1;SLIT2;STIM2;MARK1;GSN;MAP3K5;RASGRP3;THBS1;STK38L;STK3;MICU3;CDH13;IQGAP1;CDH1;PLSCR1;IRAK3;EML1;PLSCR4;FBN1;ASPN;RAP2A;MAP3K20;GSS;TPD52;MCTP2;S100A13;ERN1;TPM4;HSPE1;PDE2A;CDC42BPA;ANXA1;SRR;TPT1;CALM3;PPP3CA;NCS1;TGM2;SYT4;PAPOLA;ADCY2;HMGCLL1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ESYT3;HPRT1;APOE;S100A6;NOTCH4;S100A11;GCLC;RP2;SNN;DYSF;HACL1;CRACR2A;S100A16;POSTN;FKBP9;COMP;RET;RPE;STK38;ARSA;ANXA7;MICU2;ITPR3;CALML4;ENPP1;LRP1;CDH2;ACVR1C;AGRN;MT3;S100A10;CEMIP2;MCTP1;AOC3;MAST2;DSG2;TOP2A;TDG;LATS1;GRIN1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DSPP;MT2A;ASAH2;RASGRP2;CABYR;ACER3;DUT;ADGRL3;CDH23;MAP2K7;CALU;MAP3K6;DYRK2;SLIT1;SLIT3;MTPAP;CDH24
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.42214889747121787,-1.0808653168967612,0.3563714902807775,0.6218258247271063,1.0,4/13,10.34%,THUMPD2;TRMT10A;FTSJ1;TRMT10B
prerank,ubiquitin protein ligase activity (GO:0061630),0.25918814523830447,1.077615875072069,0.29046898638426627,0.8386238708003845,1.0,58/228,21.20%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;UBE4B;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;UBOX5;HECW1;TRIM9;TRIM32
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33053522032223864,-1.0749583975019743,0.3525641025641026,0.6321788634487696,1.0,10/33,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;RPS3;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,bHLH transcription factor binding (GO:0043425),0.39610224091867224,1.0708504978283817,0.36242884250474383,0.8538286129734912,1.0,7/19,17.55%,SMAD3;FHL2;MAP3K10;USF1;BHLHE41;SIRT1;KDM1A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4578911013285719,1.070622539216684,0.3705103969754253,0.8490015606417297,1.0,4/11,13.74%,PRMT2;FBXO11;PRMT9;PRMT3
prerank,receptor ligand activity (GO:0048018),0.2529155789618888,1.0700356717962,0.3099236641221374,0.845223065658704,1.0,23/245,7.55%,BMP7;FGF1;BMP6;WNT4;IGF1;IL18;FGF4;WNT5B;METRNL;WNT7A;IL17D;TAFA3;CHGB;FGF9;BMP3;NRTN;TNFSF13;BMP8A;NTS;COLEC10;WNT6;NRG1;INHA
prerank,NAD+ binding (GO:0070403),-0.4232370699345518,-1.06688645163905,0.4011299435028249,0.6478017636064873,1.0,4/12,23.64%,SIRT5;HADH;GLUD1;SIRT6
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.33294519156509284,-1.065784877420236,0.3673913043478261,0.6468890938188394,1.0,5/31,8.97%,SLC12A7;SLC12A2;ABCC9;SLC12A6;KCNK5
prerank,protein kinase inhibitor activity (GO:0004860),-0.31108841690647976,-1.0653837424477814,0.3431151241534989,0.6442837859054007,1.0,16/42,23.95%,YWHAB;SPRED2;CIT;RACK1;NCK1;SPRY2;CDKN1C;RPTOR;PARVA;GSKIP;TAOK3;SOCS3;IBTK;PRKRIP1;CDKN1B;SOCS1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4734787127021892,1.0633792551685541,0.3919694072657744,0.8598971163045303,1.0,5/10,24.97%,NSD1;SMYD2;NSD3;SETD2;SETD5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.45461172303073116,1.0632400896049101,0.37037037037037035,0.8548660860667874,1.0,2/10,15.16%,CDKN2A;HEXIM2
prerank,adenyl ribonucleotide binding (GO:0032559),0.24981294764245787,1.0627483195526428,0.3232758620689655,0.8509099814903337,1.0,38/291,10.79%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;PRKAG3;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;SLC19A1;MYO3A;PRKCI;KSR1;MSH6;ABCD1;OAS3;ACSS2;MPPED2;TGFBR1;MYO18A;PEX1;MTHFS
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.21393860050539643,-1.0626901671267133,0.2066115702479339,0.6471035057246373,1.0,131/597,20.49%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;BNC2;RARB;TBX15;ETS1;TCF12;MEOX2;PPARD;FLI1;KAT7;TBX3;RUNX2;FOXO3;CTCF;RUNX1;STAT3;NFATC1;PRDM16;TBX18;SIX1;GLI3;JUN;ESR1;TBX1;NFIX;DHX33;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;NFYA;PSPC1;LHX6;HES1;ETV1;NR3C2;JDP2;XRCC5;SP3;ETV5;AR;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;PRDM5;MBNL2;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;CPSF4;PER1;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;HHEX;SOX18;RARG;TBX2;ORC1;MAFF;SOX12;HSF5;SUV39H1;KLF2;MTERF3;TFCP2;NR4A2;ZW10;ARID5A;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;FOXN2;ORC2;JUNB;ZBTB37;NR2F1;HIVEP1;CDC45;FOXE1;PRDM1;IRF5;ORC5;SOX8;ZNF177;PAX3;SPI1;HOXA4;POLA1;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3949065348772338,1.0603103058874117,0.39763779527559057,0.8528158254995016,1.0,2/18,0.92%,TGFBR3;SMAD3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3429061304711552,-1.0601061817862498,0.37199124726477023,0.6498373580478931,1.0,9/27,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,cytokine receptor activity (GO:0004896),-0.27549877096014486,-1.0587481153937566,0.3485576923076923,0.6493892535336034,1.0,16/83,11.84%,GHR;IL6ST;IL1R1;OSMR;LIFR;F3;CD44;IL17RD;IL6R;IL20RB;IL1RAP;CNTFR;IL4R;IL1RL2;CD74;FZD4
prerank,magnesium ion binding (GO:0000287),-0.2488285006466488,-1.0542530239023158,0.3160493827160494,0.6571341981287627,1.0,35/135,21.15%,SNRK;MARK1;MAP3K5;STK38L;STK3;PLSCR1;IRAK3;RAP2A;MAP3K20;GSS;ERN1;PDE2A;CDC42BPA;SRR;PAPOLA;ADCY2;HPRT1;GCLC;RP2;HACL1;STK38;MAST2;TOP2A;TDG;LATS1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DUT;MAP2K7;MAP3K6;DYRK2;MTPAP
prerank,titin binding (GO:0031432),0.4266036758739684,1.0534854519917254,0.40476190476190477,0.8685056656938308,1.0,2/13,3.50%,ACTN2;CAPN3
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.34370707632510145,-1.0531052854099978,0.3726315789473684,0.6564128025910034,1.0,10/27,23.27%,POLR3F;TENT2;POLR3H;POLR1F;POLR3B;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,snoRNA binding (GO:0030515),-0.3310920482400619,-1.051401884730559,0.3747276688453159,0.6568934430145228,1.0,19/30,33.66%,XRCC5;BMS1;NUDT16;NUFIP1;NOP58;NHP2;NUDT16L1;DKC1;IMP4;NOP56;NUDT1;NOP10;DDX21;DHX37;NUDT7;TSR1;ISG20;NOP14;HEATR1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.25149692880562224,1.0499522382319484,0.34441087613293053,0.8740153546552671,1.0,57/232,21.20%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;PIAS4;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;HECW1;TRIM9;TRIM32
prerank,PDZ domain binding (GO:0030165),0.3047082594688456,1.048854645883371,0.3922942206654991,0.8721391220947801,1.0,13/61,11.42%,TGFBR3;ARHGAP29;CXXC4;GRID2;FZD8;FZD3;LLGL2;NSF;FZD7;DLG4;PDZK1;PLEKHA2;SYNJ2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.35008926866921436,1.0472072100815826,0.3981308411214953,0.8722645071511331,1.0,6/28,10.91%,PRKAA2;TNK2;MAP2K6;LRRK2;MAPK10;MAPK14
prerank,acetylcholine receptor activity (GO:0015464),0.37327786626301473,1.0459099451174585,0.3903846153846154,0.8708728707663419,1.0,3/22,10.95%,CHRM2;CHRNB2;CHRM1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.34276923650894403,-1.043909466419047,0.3757700205338809,0.6712492003562334,1.0,10/27,23.27%,POLR3F;POLR3H;POLR1F;POLR3B;PRIMPOL;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.38705739084302093,-1.0425609834461254,0.4033970276008493,0.6711386861217491,1.0,6/15,17.11%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3
prerank,poly-pyrimidine tract binding (GO:0008187),0.3732416553451406,1.040299569834304,0.3794392523364486,0.88224792020303,1.0,5/23,8.08%,RBM11;PABPC4L;HNRNPU;PATL1;PTBP1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.36414312084460565,-1.0396314620731044,0.4168466522678186,0.674811469267312,1.0,12/19,38.63%,HELQ;WRNIP1;RFC4;MCM5;MCM6;RFC2;DSCC1;HELB;CHTF18;PIF1;DHX9;POLQ
prerank,telomeric DNA binding (GO:0042162),-0.3239384325282318,-1.0390107847524717,0.4080338266384778,0.6727785190597444,1.0,14/32,26.20%,RPA1;XRCC5;HMBOX1;TERF2IP;BLM;ZBTB48;NCL;PURA;TEN1;CTC1;TINF2;UPF2;HNRNPD;TERF2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.43548335663165005,-1.03822119334749,0.4102079395085066,0.6712298977697324,1.0,3/10,6.88%,FAP;NAALAD2;PRCP
prerank,symporter activity (GO:0015293),0.4423247800025846,1.0343961706793479,0.41164241164241167,0.8950306854817768,1.0,1/10,0.70%,SLC5A5
prerank,transcription corepressor binding (GO:0001222),0.36493745552295914,1.0335061487843926,0.4118773946360153,0.892163478518792,1.0,8/27,17.96%,RORA;USP11;PHF1;LCOR;CTBP2;PER2;MTF2;HDGF
prerank,ribosomal large subunit binding (GO:0043023),0.44473354823954975,1.0332263279613079,0.4142857142857143,0.8877688063680437,1.0,3/11,7.87%,CPEB2;CPSF6;NEMF
prerank,glutathione transferase activity (GO:0004364),0.3594855253775049,1.0324206129032802,0.4116541353383459,0.8849143052761356,1.0,7/23,18.30%,GSTM2;PTGES;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4314607816818753,-1.0320479594473584,0.4240631163708087,0.6795336545095084,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4314607816818753,-1.0320479594473584,0.4240631163708087,0.6795336545095084,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,ubiquitin-protein transferase activity (GO:0004842),0.237724641849738,1.0311909046970409,0.37155297532656023,0.8833291283555249,1.0,84/346,21.25%,RNF220;RNF152;RNF43;UBE2E2;DDB2;SH3RF2;ASB2;PDZRN3;DTX1;HECTD3;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;DZIP3;MAEA;TRIM71;KLHL13;SHPRH;RNF14;FBXO11;TRIM35;DTX2;PELI3;DTX3;RNF135;TRAF7;BRAP;TOPORS;FBXO6;RNF10;RNF20;RNF6;PRPF19;RNF121;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;RLIM;PML;RING1;RNF31;FBXO17;RNF138;RNF5;RNF7;UBE2R2;RBCK1;RNF130;RNF213;KLHL20;TRIM3;MDM2;RBBP6;UBE2S;ANKIB1;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;RNF180;FBXO22;TRIM2;TRIM13;BFAR;FBXL5;KLHL42;TRIM41;NFX1;RNF146;MYCBP2;RMND5A;KLHL21;HECW1;TRIM9;TRIM32;RNF103-CHMP3
prerank,beta-tubulin binding (GO:0048487),0.3395076177911314,1.0309833281134066,0.40398550724637683,0.8788152084627132,1.0,17/31,28.25%,GJB6;EML4;IFT74;PDCD5;HTT;SMC3;CCT5;CDK5R1;DLEC1;PACRG;LRPPRC;SPAST;ARL8A;BCAS3;MAP1S;EMD;RACGAP1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.33897952554192706,1.0277432107399482,0.4032846715328467,0.8832072946563901,1.0,8/32,19.38%,KCNA3;KCNC3;KCNH2;KCNC2;KCNS3;KCNA4;KCNQ3;KCNQ5
prerank,alpha-tubulin binding (GO:0043014),0.342087791254395,1.0273152342241005,0.39579349904397704,0.8793562699274764,1.0,13/31,28.25%,EML4;DNAL1;TBCE;CDK5R1;DLEC1;WASHC1;PACRG;SETD2;SPAST;ARL8A;FNTA;TBCEL;RACGAP1
prerank,NAD binding (GO:0051287),0.352792620977071,1.026095310408425,0.41132075471698115,0.8780888789053827,1.0,4/26,10.60%,ADH4;SORD;ALDH1A1;ALDH2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.40239594407547136,-1.0253647002227857,0.4415322580645161,0.6925043652422022,1.0,4/12,17.44%,SLC6A6;SLC38A5;SLC36A4;SLC7A8
prerank,protein kinase activator activity (GO:0030295),0.3003743249191638,1.0249868545825236,0.4209650582362729,0.8761709426909853,1.0,6/60,4.06%,PRKAG2;RICTOR;GPRC5A;FAM20A;GPRC5C;GPRC5B
prerank,phosphatase binding (GO:0019902),-0.24915917431598703,-1.0240467444551655,0.35584415584415585,0.6921557899302476,1.0,35/105,21.62%,MAP3K5;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;CRY1;ANAPC5;RACK1;MET;PXN;MAPK1;SHOC2;CEACAM1;FLT4;EIF2AK3;JAK1;GTF2F1;TERF2IP;NFATC2;VRK3;SYTL2;CSRNP2;MAST2;PPP6R1;ELL;CARHSP1;RPA2;MAPK3;TRPC4AP;JAK3;MAP2K7;JUP;SH3YL1
prerank,potassium:proton antiporter activity (GO:0015386),-0.433520752295544,-1.023130185953405,0.43286573146292584,0.6910461564074699,1.0,1/10,0.96%,SLC9A2
prerank,phosphatidylglycerol binding (GO:1901611),-0.400797888605782,-1.0225254751174107,0.4359504132231405,0.6891001424089201,1.0,2/13,4.66%,PITPNC1;PLTP
prerank,fibroblast growth factor binding (GO:0017134),-0.3484417525334131,-1.0206245895380364,0.4156378600823045,0.6900946401916637,1.0,6/21,17.35%,THBS1;GLG1;S100A13;FGFRL1;GPC1;FGFR3
prerank,microtubule plus-end binding (GO:0051010),-0.3583907379274127,-1.016984270491391,0.43951612903225806,0.695325287689221,1.0,12/20,27.22%,DST;CLIP4;APC;CLIP2;CLIP1;PAFAH1B1;MAPRE2;DCTN1;KNSTRN;STIM1;MAPRE3;FBXW11
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3961804142361972,1.016936882786042,0.4166666666666667,0.8952499097280653,1.0,3/17,7.80%,DPYD;DHCR24;PTGR1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.41047252498021325,-1.0162654973620076,0.431640625,0.6936887785839657,1.0,6/12,21.15%,TENT2;PAPOLA;TENT4B;TENT5C;TENT5A;MTPAP
prerank,metalloaminopeptidase activity (GO:0070006),-0.37261851186048817,-1.0160168792158142,0.4317718940936864,0.6907921140001442,1.0,5/16,25.28%,ENPEP;LNPEP;RNPEPL1;ERAP1;XPNPEP1
prerank,active ion transmembrane transporter activity (GO:0022853),0.3266122703007435,1.014737129842999,0.42173112338858193,0.8967058588603672,1.0,8/37,12.68%,SLC22A6;SLC22A8;ATP13A3;COX7A1;COX7A2L;UQCRH;CYB5A;COX10
prerank,chemokine binding (GO:0019956),0.33691202476509685,1.013981578026854,0.43636363636363634,0.894067377200989,1.0,3/30,6.78%,CCR9;ACKR2;PDPN
prerank,lipoprotein particle receptor binding (GO:0070325),-0.32893849110520246,-1.013893250937067,0.4613733905579399,0.6925756166018958,1.0,8/27,16.64%,DNAJA1;ANKRA2;APOE;LRP1;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.33787011481750984,1.0118860102151166,0.447841726618705,0.8951555213170826,1.0,6/32,11.87%,KDM7A;BBOX1;TET1;PHF8;KDM2A;KDM4A
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3847131295973988,-1.0084379094744877,0.46021505376344085,0.70241038865364,1.0,4/15,10.77%,PLA2G4A;SH3PXD2B;PLEKHA5;JPH2
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28104156838967675,-1.0072594777999178,0.45852534562211983,0.7018316698266778,1.0,19/52,23.82%,ACTN4;TACC1;ETS1;DCAF6;ACTN1;SLC30A9;FGF2;ELK1;SS18;TMF1;NCOA6;ENY2;MED14;ZMIZ2;ZMIZ1;MED13;NCOA3;CCDC62;MED24
prerank,DNA polymerase activity (GO:0034061),0.3624131974501576,1.0042846075571936,0.4467680608365019,0.912450283251099,1.0,8/22,19.85%,POLM;REV1;TERT;POLI;POLE;POLG;POLN;POLE4
prerank,GABA receptor activity (GO:0016917),0.3597430136152166,1.0036203740019967,0.42658730158730157,0.9093435239231621,1.0,6/21,18.56%,GABRG1;GABBR1;GABBR2;GABRG3;GABRB2;GABRB3
prerank,phosphatase activator activity (GO:0019211),-0.377510176483362,-1.000822360317468,0.4574468085106383,0.7138630551763743,1.0,6/14,20.73%,CALM3;PPP2R5C;GTF2F1;BMP2;B3GAT3;PPP2R5B
prerank,serine-type endopeptidase activity (GO:0004252),0.27650862384613384,0.9991503267775765,0.4573913043478261,0.9178189671272324,1.0,16/80,18.74%,PCSK4;FURIN;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;PRSS36;HGF;KLK1;PRSS53;DPP4;RHBDF1
prerank,DNA binding (GO:0003677),0.21670385808074635,0.9984645055426057,0.46786632390745503,0.9148192242912497,1.0,157/694,20.17%,DENND4A;RORA;EPAS1;HLF;NUPR1;SMAD3;DDB2;APLP2;SPHK1;MSX2;CXXC5;THRB;SCRT1;CHD4;ARID4A;NR6A1;PPARA;NFYB;ESRRA;SLTM;ERCC1;PMS2;SIM1;POLRMT;TET1;MEIS1;AIFM1;PCID2;PQBP1;PAX6;IKZF1;RBPJ;DNMT3A;AUNIP;ARID3A;HNRNPU;TFPT;HOXA7;PBX4;NFYC;ZKSCAN3;SUPV3L1;E2F1;CEBPA;MEIOB;SPRTN;NR2F2;CHD3;MSH4;KDM5B;NLRP3;PHF1;MBD4;MAFA;MSH6;PPARGC1A;HINFP;MAX;ZNF711;NR1H3;ZDHHC1;ZBTB22;ZIC2;SSBP2;TDP2;RXRA;CLOCK;CR2;PRDM2;PSIP1;SSBP1;PARP4;MRE11;TOPORS;CSRNP3;BCL2;WBP11;BCLAF3;E2F4;CSRNP1;STAT1;USF1;BATF;ZFPL1;FUBP1;MBD1;TAF1;ZBTB49;SOX9;PURB;MSH3;TERT;HDAC4;FOXC1;MEN1;ARNT;PLAGL2;RAD51D;RNF138;CENPC;POLR3C;POLE;AIFM2;TLR8;PRKDC;RPA3;RBM5;SAFB2;ERF;ABL1;HIC2;MCM7;POLR2D;HDGFL2;ILF2;POLG;GTF3C1;LHX4;TRNP1;MCMDC2;SAFB;CLSPN;CAMTA2;SOX6;RELA;MTF2;RAD52;SRRT;TCF7L2;TCF4;HDGF;SMC1B;NHEJ1;TSHZ3;ZBTB6;ARID5B;MLXIPL;MLX;FOXL1;TFAP4;POU6F1;MEF2A;SOX2;HMCES;LONP1;MEIS3;RFX2;COLEC11;DDIT3;POLR2A;SNAPC1;GTF3C4;POU2F2;ILF3;CGGBP1;DDX3X;SPTY2D1
prerank,ATPase activator activity (GO:0001671),0.37176672408458167,0.9974209481306504,0.45617529880478086,0.912956284080218,1.0,4/20,9.18%,ATP1B3;ATP1B2;DNAJB4;DNAJC10
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4122411845353614,-0.9969629443190848,0.4688715953307393,0.7199073426354137,1.0,5/11,26.20%,RPA1;TERF2IP;RPA2;CTC1;TERF2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3121856918735491,0.9958122381817016,0.4548802946593002,0.9126062209779839,1.0,11/44,13.73%,KMT5A;DOT1L;KMT2A;N6AMT1;NSD1;SETD4;KMT5C;SETD7;SMYD3;SMYD2;MEN1
prerank,GTPase binding (GO:0051020),-0.22373499507976938,-0.9934593714657717,0.49019607843137253,0.7255437742657637,1.0,36/195,12.53%,SPTBN1;CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;RASIP1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;GNB1;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D;ATG16L1;WHAMM;CDC42EP2;GNB2;FNBP1L;RANBP9;ARHGAP1
prerank,RNA binding (GO:0003723),-0.1912258481869969,-0.9931898271377384,0.5112781954887218,0.7227371201356124,1.0,300/1321,19.30%,SPTBN1;MBNL1;SYNE1;SORBS2;ACTN4;AHNAK;DCN;RFTN1;TMSB4X;LRRFIP1;FNDC3B;FNDC3A;YWHAE;SPATS2L;RBPMS;RPS15;MYH9;RPL38;RPL18A;RPL41;MACF1;RBM3;STAT3;EEF1A1;RPS12;RPS20;ZMAT3;AGO1;DARS1;FAU;QKI;RPL32;RPL5;ADARB1;CAST;ZC3H7A;UBC;RPS10;DAP3;CTNNA1;CS;DHX32;RPL10;RPS23;RPS24;JUN;GTPBP10;EIF3E;RPL7;ALKBH1;RPL37A;ACTN1;KCTD12;SERBP1;FLNA;EIF3H;DHX33;GNL3;SMC1A;CCDC9B;CPNE3;TFRC;MAP3K20;DCP1B;CISD2;RPS17;DNAJC21;RPS16;MRPL20;CSNK1E;RPL39;RPS27A;FASTKD1;PABPC1;TRNAU1AP;PSPC1;RBM33;MAP4;EXOSC1;PRR3;FCF1;RACK1;RPL13;SNRNP200;HSPE1;XRCC5;EEF2;YBX3;PPIA;RPLP0;CDC40;RPL30;REXO4;RBM28;RPS5;TRIM56;SMNDC1;RPL35A;PSMA6;TPT1;RPS8;RPF1;SYF2;TRIM25;MRPL21;NOVA2;PUM2;SIDT2;SNRPD1;RPS7;RPL22;ALDOA;MYBBP1A;MBNL2;RPS3;RPS28;KTN1;G3BP1;FRG1;RPL29;SPEN;BMS1;SRP19;RPL7A;RPS26;LSM7;GFM1;THUMPD1;PTPN1;SURF6;RPL6;RPL18;RPS25;EIF4E;TENT4B;PELP1;AGO2;RPL36;TRMT10A;COL14A1;DDX54;RPL28;RBM42;GTF2F1;YWHAZ;FASN;RPL27;DROSHA;TRMT10B;LARP1B;RSRC2;CPSF4;ZCCHC24;LRRC59;TCF20;RTF1;RPL24;FBRSL1;WDR33;RPL23;RPL17;MRPL23;TES;DIDO1;YARS2;SECISBP2L;S100A16;MRPS31;HSPB1;IPO5;RPS9;RPS27;SNRPD2;YLPM1;NCBP2;NMD3;NCOA5;NGRN;TDRD7;RPL22L1;SYNCRIP;TNS1;PDIA4;RRP7A;DCAF13;RBM7;KIN;TPR;SAP18;R3HDM1;UBE2L3;RPL21;FUS;MRPL10;ELAC2;ERH;PFN1;ACAA2;RPL34;ANXA7;HNRNPAB;PEBP1;RPL10A;RBM6;LRP1;KMT2C;PPP1CC;RPL12;RBFOX2;POLR1G;TASOR;UBAP2L;PUM1;RPL35;RBMS3;CMSS1;CCDC124;RPL14;ZC3H4;CAVIN1;MRPL12;IFIH1;ALDH18A1;SRP14;DDX27;DDX23;EIF1B;ESF1;NCBP1;KPNA2;SRSF3;AQR;DHX38;TEP1;KIF1C;EIF4G3;RPL19;HELZ;DDX49;GLRX3;DHFR;FMR1;RPL37;RPS18;PA2G4;PPIE;RRP12;PDAP1;RPS13;RBM10;UNC50;RPS15A;TBRG4;RTN4;DDX25;RPP21;RPP38;RBM25;DNAJC2;RRBP1;PTCD3;FXR1;MRPS12;PCBP2;MRPL1;NUSAP1;ADAT1;N4BP1;TOP2A;HDAC2;DUS3L;MRPL43;SRPRA;DYNC1H1;PWP2;AGO4;MRPL45;NUDT16;HMGN2;BARD1;MANF;CSTF1;ZCCHC3;MCAT;PCBP1;ASS1;XPO5;MRPL44;RIDA;AIMP1;DSP;USP10;CKAP4;NTPCR;ZC3H12A;NUFIP1;UBTF;DIMT1;RBM46;CHCHD1
prerank,methylated histone binding (GO:0035064),0.2894555967812567,0.9914315957984747,0.4691780821917808,0.9212159153470416,1.0,11/62,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;TAF1;KDM4A
prerank,methylation-dependent protein binding (GO:0140034),0.29338432231495437,0.9908947488504857,0.4670138888888889,0.9179298989098043,1.0,10/57,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;KDM4A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3768845304024445,-0.9889997078899229,0.4745098039215686,0.7296116476284918,1.0,1/15,0.90%,PLA2G4A
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.32312240238852175,0.9885315950670076,0.45080500894454384,0.9202187554105202,1.0,12/35,15.95%,TRMT9B;TARS2;NT5C3A;MRPL58;BCDIN3D;DUS1L;TRPT1;QRSL1;QTRT2;QTRT1;MTFMT;DTWD2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29024598972069254,-0.9858687586443904,0.46652267818574517,0.7338716911078194,1.0,16/40,23.07%,METTL2B;METTL2A;THUMPD2;NNMT;PCMTD2;PRMT7;ASMT;DNMT3B;PCMTD1;SUV39H1;ICMT;GAMT;MEPCE;LCMT1;DNMT1;HNMT
prerank,transcription cis-regulatory region binding (GO:0000976),-0.20580126025198947,-0.9846649792019831,0.5035211267605634,0.7334314076574646,1.0,60/406,12.36%,LEF1;FOXP1;MEF2C;ACTN4;PBX1;ELK3;TRPS1;BNC2;ETS1;PLAGL1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;AGO1;TBX18;SIX1;ZNF25;DACH1;GLI3;JUN;ZBTB46;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;LHX6;ZNF3;XRCC5;TWIST2;SP3;ETV5;AR;KLF11;ZNF436;FOXN3;PRDM5;RPS3;ELK1;AGO2;AHR;IRF2;KLF4;TAL1;MAFK;ETV6;RFXAP;PER1;SOX7;TWIST1;TEAD1;HHEX;SOX18;FOXF2;FOSL2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40591078470652703,-0.9830252828472152,0.4657534246575342,0.7338071038259694,1.0,3/11,13.26%,DAB2IP;ROR2;STK38
prerank,DNA polymerase binding (GO:0070182),0.37823965062042403,0.9818374113702177,0.4806949806949807,0.9351640415256354,1.0,6/18,19.37%,FANCD2;FANCI;RTEL1;SMG6;HSP90AA1;LONP1
prerank,voltage-gated chloride channel activity (GO:0005247),0.4263305811341124,0.9809216643634017,0.4698544698544699,0.9328479620800526,1.0,4/10,13.33%,CLCN6;CLCN2;CLCN4;CLCN3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.37785564541311945,-0.9798021388361641,0.49295774647887325,0.7380354477377922,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,endodeoxyribonuclease activity (GO:0004520),0.3600878673021377,0.976869760699107,0.4652908067542214,0.9396597942037545,1.0,4/20,16.96%,ERCC1;MBD4;MRE11;EXOG
prerank,DNA-binding transcription factor binding (GO:0140297),0.23981668036752266,0.9757657119862637,0.4984472049689441,0.9377810563958134,1.0,36/189,14.03%,ZMYND8;SMAD3;MAGEA2;CXXC5;BEX1;FHL2;CHD4;PPARA;NFYB;POU1F1;GTF2I;IFI27;RBPJ;ATN1;KAT5;NLRP3;MIER3;HES6;MAP3K10;DMAP1;BBS5;LDB2;LDB1;BCL2;STAT1;USF1;TTC8;TAF1;ZBTB49;BHLHE41;PURB;PIAS4;GABPA;HDAC4;NOC2L;PSMC5
prerank,sequence-specific DNA binding (GO:0043565),0.2153367731271353,0.9748008042678769,0.5634178905206942,0.9359217873734469,1.0,70/590,11.18%,MAF;RORA;EPAS1;HLF;CREB5;SMAD3;OSR1;NR2E1;HMX2;MSX2;CXXC5;OVOL2;THRB;ZSCAN29;ZBTB38;CXXC4;SCRT1;MYBL2;FBXL19;NR6A1;ARNT2;PPARA;ZNF23;ESRRA;POU1F1;SLTM;UBP1;HOXB9;KMT2A;POLRMT;MAFG;TET1;PAX6;RBPJ;HNRNPU;ZBTB26;HOXA7;PBX4;DRGX;ZKSCAN3;E2F1;DPF1;HOXB6;BCL11B;NR2F2;TEF;KLF15;KDM5B;NLRP3;HES6;MAFA;PPARGC1A;KDM2A;MAX;ZNF711;E2F8;ZBTB22;HOXB4;RXRA;CLOCK;PRDM2;SMG5;CSRNP3;BCL2;E2F4;CSRNP1;USF1;BATF;MBD1;TAF1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.42524074886914087,0.9745825312665353,0.4980392156862745,0.9316973461534668,1.0,3/10,15.51%,RENBP;GFUS;DSE
prerank,thioesterase binding (GO:0031996),-0.40982842998220687,-0.9740059712908457,0.510556621880998,0.7483066367296766,1.0,3/11,20.49%,TRAF5;CDC42;TRAF4
prerank,galactosyltransferase activity (GO:0008378),0.42384719771797047,0.9735436041424358,0.504930966469428,0.9297517842214543,1.0,4/11,8.84%,B4GALT2;B4GALT1;B3GALT6;B4GALT3
prerank,metalloendopeptidase activity (GO:0004222),-0.2553208912915492,-0.972592772778746,0.5150812064965197,0.7484025766405118,1.0,17/76,17.35%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;ADAMTS17;ADAMTS6;ADAM10;ADAMTS1;ADAM19;ADAMTS14;MMP11;ADAMTS20;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2
prerank,peptidase activator activity (GO:0016504),-0.3278113309082409,-0.9724431000917153,0.4904862579281184,0.7453470485593062,1.0,7/22,21.47%,CAV1;CASP8AP2;PCOLCE;ADRM1;PSMD14;PSENEN;PSME1
prerank,calcium ion binding (GO:0005509),0.2232677360533141,0.9688151146004591,0.5283018867924528,0.9390575081011153,1.0,45/323,12.06%,SYT11;SYT12;DSC2;DSC3;ANXA6;MAN1C1;ADAMTS13;FBLN1;PON1;CPNE1;PLSCR2;ENPP3;ANXA5;CDH15;CDH3;CDH17;S100A4;CAPN3;SMOC2;SYT9;ITPR1;PLA2G4C;SYT1;CDH10;CALR3;CDH18;SYT13;CRNN;ADGRV1;SLC25A12;SLC25A23;SYT10;GJB2;ITPR2;AMY1B;AMY1C;AMY1A;RYR2;GALNT3;TRPM2;CANX;DMP1;CCDC47;KCNIP4;CPNE6
prerank,tau-protein kinase activity (GO:0050321),0.36042608488734507,0.9684569558225621,0.4952919020715631,0.93520690106944,1.0,3/20,4.82%,ROCK2;PHKG2;TTBK2
prerank,transition metal ion binding (GO:0046914),0.2183697676626752,0.967659847933246,0.5558659217877095,0.9327799559224307,1.0,59/397,12.63%,MOXD1;UPB1;ZMYND8;SMAD3;KDM7A;ADH7;ADH4;ADAMTS13;CXXC5;SORD;CXXC4;ENPP5;CHD4;FBXL19;ENPP3;ETHE1;PITRM1;PPM1M;BBOX1;GLRA1;LOXL3;KMT2A;ARG2;TET1;PHF8;LARGE1;B4GALT1;LACC1;GALT;CHD3;QPCT;KDM5B;PHF2;CSRP1;KDM2A;CPA2;TDP2;RXRA;TRAF7;PRDM2;MPPED2;NSD1;CUTC;HRG;DOHH;ZFPL1;MBD1;PLA2G15;GALNT3;KDM5C;EPRS1;ENDOU;RABGGTB;KDM4A;GYG1;GALNT2;RBAK;FDX1;PIAS4
prerank,ion gated channel activity (GO:0022839),-0.32845291258015546,-0.9665297565592972,0.4935064935064935,0.7561307740379831,1.0,5/24,16.00%,KCNT2;ANO1;TTYH2;ANO4;ANO2
prerank,ephrin receptor activity (GO:0005003),0.37520983285104764,0.9659074142379145,0.5181644359464627,0.9288273431369387,1.0,5/17,15.97%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.37520983285104764,0.9659074142379145,0.5181644359464627,0.9288273431369387,1.0,5/17,15.97%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.29183296789453295,0.9656567724834432,0.503731343283582,0.9249079882494929,1.0,11/49,13.57%,OPTN;DZIP3;TNIP3;IKBKG;ABRAXAS1;ZFAND6;SPRTN;TNIP2;IKBKE;BAG6;OTUD7A
prerank,proton transmembrane transporter activity (GO:0015078),0.3020429262405611,0.9655930298984322,0.5294117647058824,0.9205098897615905,1.0,9/39,13.33%,COX7A1;COX7A2L;ATP6V1B2;UQCRH;CLCN4;CYB5A;MFSD3;COX10;CLCN3
prerank,voltage-gated anion channel activity (GO:0008308),0.38316890750784505,0.9645640349016338,0.49706457925636005,0.9187155447904551,1.0,6/15,17.31%,CLCN6;CLCN2;CLCN4;CLCN3;VDAC1;VDAC2
prerank,cation transmembrane transporter activity (GO:0008324),0.2886640017947314,0.9615513067950745,0.498220640569395,0.9225325053215627,1.0,10/48,15.68%,SLC41A1;SLC38A3;SLC6A9;SLC38A1;SFXN2;SLC38A9;SLC66A1;SLC22A2;SLC38A7;MMGT1
prerank,small GTPase binding (GO:0031267),-0.21967401003775175,-0.9611653224843287,0.6005361930294906,0.7658789581653748,1.0,26/170,9.06%,CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D
prerank,adrenergic receptor binding (GO:0031690),0.36365305367207396,0.9566579884576057,0.49,0.9318112994732449,1.0,5/16,9.85%,MAGI2;ADRA2A;ARRDC3;DLG4;C1QBP
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.21553782380364234,-0.9548884584808331,0.6092307692307692,0.7780123065253712,1.0,29/181,11.88%,ACTB;ACTN4;TACC1;MDFIC;PPARD;TBX3;NFKBIA;LMO2;STAT3;NFATC1;MIER1;CRY1;JUN;DNAJA1;BHLHE40;HES1;PSMA6;AR;NRIP1;SPEN;HEY2;ZFPM2;ARID1A;ELK1;KLF4;TAL1;MYOCD;HSPB1;MTA1
prerank,anion transmembrane transporter activity (GO:0008509),-0.3901547291900888,-0.9544920895194228,0.5099206349206349,0.7755054579183123,1.0,3/12,4.90%,ABCG2;SLCO2B1;SLC39A8
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.35375719535590583,-0.9508086519356815,0.52834008097166,0.7809669905815704,1.0,6/16,22.82%,CD38;RPS3;OARD1;TDG;NEIL3;SMUG1
prerank,endopeptidase inhibitor activity (GO:0004866),0.2625006166313384,0.9506102303143197,0.5280135823429541,0.9438965861357091,1.0,8/82,5.67%,TFPI;ITIH2;COL4A3;TIMP3;RENBP;SERPINA10;FURIN;SERPIND1
prerank,protein phosphatase regulator activity (GO:0019888),0.2806911340029315,0.9474800809974948,0.5498220640569395,0.9480749809844309,1.0,6/53,8.96%,PPP2R2B;PPP1R16A;DMPK;PPP4R4;PHACTR4;EIF2AK2
prerank,metallopeptidase activity (GO:0008237),-0.23235463062792758,-0.9454711903421261,0.585427135678392,0.7905844410378078,1.0,26/113,18.06%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;EIF3H;ADAMTS17;LAP3;ADAMTS6;ADAM10;PAPPA;ADAMTS1;ADAM19;ADAMTS14;MMP11;METAP1D;ADAMTS20;ACE2;LNPEP;ADAM15;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2;NUDT16;PSMD14
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2032932657439086,0.9452660863538225,0.6835599505562423,0.9498044173072994,1.0,91/830,10.09%,AEBP1;ZKSCAN2;MAF;RORA;EPAS1;HLF;CREB5;SMAD3;KCNIP3;NPAS3;OSR1;NR2E1;HMX2;MSX2;SOX5;OVOL2;THRB;ZSCAN29;ZBTB38;SCRT1;MYBL2;CREBRF;NR6A1;ARNT2;PBX2;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;UBP1;HOXB9;TFDP2;SIM1;ENO1;HOXB3;MAFG;MEIS1;PEG3;CCAR1;RUVBL2;MLXIP;PAX6;IKZF1;RBPJ;IKZF2;MZF1;DNMT3A;HNRNPU;ZFHX2;ZBTB26;HOXA7;PBX4;RFX8;NFYC;DRGX;ZKSCAN3;E2F1;CEBPA;HOXB6;BCL11B;NR2F2;TEF;KLF15;ZSCAN22;HOXA3;ZNF569;KDM6B;ZNF467;HES6;MAFA;HINFP;HIF3A;MAX;NR1H3;E2F8;ZBTB22;HDX;ZIC2;HOXB4;RXRA;CLOCK;ZFP90;PRDM2;NSD1;SALL3;FOXP4
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3833983088603795,-0.9450795456636647,0.5468409586056645,0.7880551409254544,1.0,5/12,13.71%,INSR;PIK3R1;SOCS2;IGF2;IRS1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.40469629503273674,0.9426498424873407,0.506,0.9523572875354446,1.0,6/11,25.96%,UBE4B;PRPF19;UBOX5;AMFR;UBR5;RBX1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.37980295267490294,-0.9416536365910076,0.5506072874493927,0.7926243844976949,1.0,3/12,13.71%,PIK3R1;SH2B2;IRS1
prerank,MHC class II protein complex binding (GO:0023026),-0.3923545312071265,-0.9416309367865993,0.5390946502057613,0.7891908331717514,1.0,2/11,11.83%,YWHAE;CD74
prerank,cAMP response element binding (GO:0035497),0.4005261190236238,0.9408810898766435,0.50293542074364,0.9526737757138608,1.0,1/10,0.61%,CREB5
prerank,solute:proton symporter activity (GO:0015295),-0.35493123906386237,-0.9407211328834955,0.5641547861507128,0.7878417177371386,1.0,3/16,13.11%,SLC2A13;SLC39A8;SLC2A9
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3192619570930574,0.9404728369297385,0.5377532228360957,0.9492712124498126,1.0,5/29,9.70%,SLC13A3;SLC26A1;SLC25A11;SLC19A1;SLC25A12
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3703138935836325,0.9389434615741656,0.5240963855421686,0.9490596131453822,1.0,4/14,8.72%,ACO1;CIAO3;NDUFS1;EXO5
prerank,nucleotidase activity (GO:0008252),-0.35733247466342966,-0.9377612583018848,0.506578947368421,0.7917663819271169,1.0,5/15,22.13%,BPNT2;NT5C1A;NT5E;NT5C;ACP3
prerank,myosin II binding (GO:0045159),-0.3960121378125486,-0.9371410070171288,0.5548523206751055,0.7897463445440707,1.0,2/10,1.86%,SHROOM4;GSN
prerank,nucleotide diphosphatase activity (GO:0004551),0.3728098379802783,0.936908041824356,0.525879917184265,0.9498640558238658,1.0,4/14,13.39%,ENPP5;NUDT4;CILP2;NUDT11
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3079608070001102,0.9368971850899925,0.5522935779816514,0.9454530912490586,1.0,7/33,13.15%,CTR9;CCAR2;HNRNPU;LLPH;CDC73;RPRD2;SMYD2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3156568135497198,-0.9344200002837486,0.5669456066945606,0.7924236369728889,1.0,7/22,16.64%,DNAJA1;ANKRA2;APOE;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,solute:sodium symporter activity (GO:0015370),0.3217663206162067,0.9343733335513547,0.5438931297709924,0.947565035507321,1.0,4/27,9.13%,SLC5A3;SLC5A10;SLC4A9;SLC34A3
prerank,phospholipase A2 activity (GO:0004623),0.3195315572121488,0.9340309933919583,0.5403377110694184,0.9442420564678753,1.0,6/26,16.09%,PLAAT5;PLA2G4C;PNPLA8;PLA2G15;ABHD3;PLAAT3
prerank,histone deacetylase activity (GO:0004407),-0.3401076059241181,-0.9333260661171794,0.5681818181818182,0.7915305452024185,1.0,7/19,23.64%,MIER1;HDAC9;HDAC6;HDAC2;MIER2;SIRT7;SIRT6
prerank,GTPase inhibitor activity (GO:0005095),0.3803302777461965,0.9319448624470377,0.5357142857142857,0.9452947583375898,1.0,3/13,6.94%,CPEB2;TNK2;ARL2
prerank,serine-type peptidase activity (GO:0008236),0.2526068194442634,0.9314692769568883,0.5657237936772047,0.942288654877054,1.0,19/96,18.74%,PCSK4;FURIN;PREP;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;ENDOU;PRSS36;HGF;KLK1;ST14;PRSS53;DPP4;RHBDF1
prerank,manganese ion binding (GO:0030145),0.2904657450325867,0.931297990265558,0.5650623885918004,0.9384363198331038,1.0,12/48,15.25%,PPM1M;ARG2;LARGE1;B4GALT1;TDP2;MPPED2;GALNT3;ENDOU;GYG1;GALNT2;GALNT1;ABL1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.38435122777706104,0.9303454191694452,0.5602294455066922,0.9365781024472857,1.0,4/13,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,hormone activity (GO:0005179),0.27545995680049695,0.9301327900142038,0.5596491228070175,0.9328980390892208,1.0,6/54,11.22%,IGF1;METRNL;CHGB;INHA;VIP;GRP
prerank,neuropeptide receptor binding (GO:0071855),0.37381003887787045,0.9300356583189497,0.5584158415841585,0.9289179291839809,1.0,2/14,7.70%,NTS;SHANK1
prerank,ubiquitin binding (GO:0043130),-0.24277124846666695,-0.92917055837138,0.5924170616113744,0.7977005574936264,1.0,27/73,26.65%,FAF2;NBR1;UBXN1;VPS36;DDI2;USPL1;MVB12B;HSPB1;SQSTM1;RAD23B;UBXN2A;FBXW7;AUP1;ADRM1;N4BP1;TOP2A;UCHL1;NEDD4;GGA3;FAF1;TOM1L1;NUP62;TSG101;CXCR4;OTUB2;RNF168;OTUB1
prerank,Notch binding (GO:0005112),0.3394707321880145,0.9273403611623954,0.5534351145038168,0.9320543348690754,1.0,3/22,3.43%,SNED1;DTX1;GALNT11
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.40530176813510893,0.9252258159692672,0.5525773195876289,0.9331461612911152,1.0,3/10,14.21%,OTUD4;STAMBP;DESI2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3164124423655359,0.9234823520530958,0.5764023210831721,0.933404196869965,1.0,6/27,10.60%,SLC41A1;SLC23A1;ITPR1;TUSC3;MAGT1;ITPR2
prerank,ribosomal small subunit binding (GO:0043024),0.347745711904927,0.9217090329314006,0.5348837209302325,0.9339785237914086,1.0,1/17,0.46%,CPEB2
prerank,glycine binding (GO:0016594),0.39404473306417775,0.920995045871055,0.556,0.9317627647205262,1.0,3/11,6.12%,GRIN3A;GLRA1;GLDC
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3634774634232474,0.9207989956052203,0.5305719921104537,0.9281995026344927,1.0,4/14,21.76%,CAPN3;CAPN15;CAPN10;CAPN11
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.26608459960463593,0.9202283961002738,0.5916230366492147,0.9255718030493378,1.0,14/60,16.68%,LRRK1;PPM1M;PPEF2;CTDSPL;PPM1G;LRRK2;PPM1D;PPP1CB;CDC14B;PPP6C;PPP2CB;PPP3R1;UBLCP1;PPM1B
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2687015234889668,0.9196491495287794,0.5989208633093526,0.9230355633077072,1.0,15/53,17.55%,DDO;DPYD;AIFM1;MICAL3;QSOX1;KMO;NDOR1;GCDH;SQLE;AIFM2;LDHD;CYB5R1;MTHFR;ILVBL;KDM1A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.37281876835009103,-0.9187698573586354,0.5694164989939637,0.8183112874481739,1.0,6/12,15.28%,PIK3C2A;PIK3R6;PIK3CA;PIK3CD;PIK3C3;IPMK
prerank,heme binding (GO:0020037),0.2645137408998858,0.9187399615390156,0.6042031523642732,0.9213581198811294,1.0,14/65,14.39%,CYP26B1;CYP11B1;SDHD;FLVCR1;EIF2AK1;CYP27A1;CYCS;HCCS;SDHC;HRG;SLC48A1;CYB5A;CYP51A1;PGRMC1
prerank,androgen receptor binding (GO:0050681),0.3208252720774307,0.9183244314766729,0.5665399239543726,0.9185218126328174,1.0,6/25,10.62%,DDX5;PRMT2;RNF14;NSD1;PRKCB;RNF6
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3338583837499448,0.9163283775227679,0.5659655831739961,0.9198369585903137,1.0,7/21,19.85%,POLM;REV1;POLI;POLE;POLG;POLN;POLE4
prerank,inward rectifier potassium channel activity (GO:0005242),0.320944712109808,0.9158936533679285,0.5630885122410546,0.9170566830197906,1.0,5/24,9.74%,KCNJ13;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2060005218617241,0.914536981898243,0.7313432835820896,0.9165202324010714,1.0,47/431,10.43%,ATP1A2;PRKAG2;ANXA6;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;RRAGC;OAS2;WNK3;RHOBTB2;BMPR1A;RAB42;RAB21;ATL1;GBP3;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;ARL2;PRKCI;LRRK2;KSR1;ARL5B;MSH6;ABCD1;RIT1;RHOQ;OAS3;TUBG1;DRG1;TGFBR1;RHOU;MYO18A;PEX1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3672390969251994,-0.9134117110768796,0.5828343313373253,0.827246148299124,1.0,2/12,6.34%,SLC2A1;SLC2A3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3603614079830881,-0.9116084194996048,0.5685884691848907,0.8280589443490458,1.0,3/12,10.37%,ENTPD1;ENTPD6;ENTPD2
prerank,telomerase RNA binding (GO:0070034),0.3289995806862983,0.9100181725594039,0.6,0.9238826895162386,1.0,10/22,25.38%,HNRNPU;SMG5;TERT;SMG6;GAR1;SNRPB;PINX1;DCP2;HNRNPC;WRAP53
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3690418153804151,-0.9098321338820973,0.570264765784114,0.8287491324788027,1.0,11/12,53.08%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,SH2 domain binding (GO:0042169),-0.2865702506386513,-0.9079278330427556,0.5975103734439834,0.8297408874867885,1.0,8/31,13.71%,AFAP1L2;SH3PXD2B;RACK1;SRC;SQSTM1;SH2B2;TRPV4;IRS1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3309545978837277,0.9061961574646926,0.5637065637065637,0.9298430168565462,1.0,8/19,28.29%,DERL1;LCOR;BAG6;CHMP3;SART3;AMFR;SUMO1;PRKN
prerank,calcium activated cation channel activity (GO:0005227),-0.3301066818507587,-0.9018813462976211,0.6029411764705882,0.8400257964331205,1.0,7/17,31.54%,ANO1;KCNMB2;ANO6;ANO10;KCNN1;KCNMB4;KCNMA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.34496575322608347,-0.9016793347687172,0.6112266112266113,0.8369151625001569,1.0,4/14,12.11%,SPOCK2;NGF;RECK;LXN
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3492622787522104,0.9014435095284742,0.5792563600782779,0.9337238574682934,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3492622787522104,0.9014435095284742,0.5792563600782779,0.9337238574682934,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,lipase activator activity (GO:0060229),0.39971284238408555,0.8993172895396531,0.5725971370143149,0.9350564777788528,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,sequence-specific mRNA binding (GO:1990825),-0.3742914947617326,-0.896463105084518,0.5964912280701754,0.8451372316479837,1.0,4/10,25.44%,DHFR;FMR1;RBM24;TYMS
prerank,protein kinase C binding (GO:0005080),-0.26251733855965753,-0.89523463700215,0.6688888888888889,0.8443948950099224,1.0,14/43,18.88%,PDLIM5;CAVIN2;ADCY4;RACK1;HDAC7;HDAC9;HSPB1;SQSTM1;GRK5;TRPV4;IRS1;TOP2A;HINT1;DSP
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.33828114652194957,-0.8951330014861577,0.6004273504273504,0.841099808085496,1.0,3/15,12.49%,SLC1A5;SLC1A3;SLC1A1
prerank,microtubule minus-end binding (GO:0051011),0.3621947881549238,0.8935366583602559,0.6061224489795919,0.9452544942223751,1.0,3/13,9.37%,TUBGCP5;CEP290;TUBGCP4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3926091478190288,0.8924798756315885,0.5954825462012321,0.9439119781007327,1.0,3/10,16.81%,CRMP1;DPYSL2;OPLAH
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2753585739465131,-0.8896946410742976,0.6184486373165619,0.8462683162900523,1.0,9/34,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2753585739465131,-0.8896946410742976,0.6184486373165619,0.8462683162900523,1.0,9/34,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,tau protein binding (GO:0048156),0.27873764847336047,0.8887555003957246,0.6432532347504621,0.9488390821178913,1.0,4/40,4.82%,ROCK2;MAP2;PICALM;TTBK2
prerank,ankyrin binding (GO:0030506),0.3326695089627877,0.888536351359074,0.6029684601113172,0.9454879968745191,1.0,2/19,2.85%,CACNA1D;FLNC
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.35334372998769736,0.8884628814425031,0.6097560975609756,0.9417617071014932,1.0,6/14,26.55%,SLC7A11;SLC25A12;SLC38A7;SLC25A13;SLC25A18;SLC17A8
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.36877450252752275,0.8879222984598335,0.5853658536585366,0.939260465599593,1.0,4/12,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.36629305435270754,-0.8871039560621672,0.6199616122840691,0.8480239353150527,1.0,4/11,19.69%,AKR1B1;AKR1A1;RDH11;DHRS13
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27157872994447935,-0.8848607516212896,0.6349557522123894,0.8492223656394069,1.0,3/35,3.38%,FOXP1;H3-3A;AGO1
prerank,nuclear receptor binding (GO:0016922),0.2338372649991403,0.8841809187266074,0.6937394247038917,0.9445498692665476,1.0,19/111,11.18%,PPARGC1B;DDX5;SMAD3;BRD8;HMGN3;SMARCD3;PRMT2;RNF14;MED1;PPARGC1A;TAF10;MED25;RXRA;NSD1;PRKCB;RNF6;LCOR;STAT1;TAF1
prerank,palmitoyltransferase activity (GO:0016409),0.29717827715419387,0.8835762254180813,0.6216730038022814,0.9421967482038687,1.0,9/28,17.45%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,FMN binding (GO:0010181),-0.36137457512716015,-0.8808256568699121,0.6365384615384615,0.8545284620579402,1.0,5/11,32.22%,NOS3;POR;PNPO;NOS2;NOS1
prerank,protein phosphatase 2A binding (GO:0051721),-0.2972904086941136,-0.879934014399215,0.6313559322033898,0.85303888811395,1.0,4/23,5.44%,DAB2IP;FOXO1;MFHAS1;STRN3
prerank,iron ion binding (GO:0005506),0.2685417085259367,0.877500511889236,0.6542553191489362,0.952798941258277,1.0,9/48,13.53%,KDM7A;ETHE1;TET1;PHF8;HAAO;PHF2;DOHH;FDX1;CDO1
prerank,ATPase regulator activity (GO:0060590),-0.26102612608727993,-0.8766447721760953,0.6629213483146067,0.8564218606926483,1.0,11/38,17.83%,DNAJC1;DNAJA1;FNIP2;DNAJA2;BAG5;PFN1;GRPEL1;KATNB1;BAG1;PLN;TOR1AIP2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.37468770061904566,0.8721986398979942,0.6178343949044586,0.9616948842809078,1.0,4/10,9.52%,SHISA7;SHANK1;NSF;DLG4
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3218661615305821,-0.8707368019623841,0.6470588235294118,0.8652263242353142,1.0,5/16,16.14%,SLC26A7;SLC26A2;SLC1A1;SLC26A6;CFTR
prerank,GABA-A receptor activity (GO:0004890),0.32354581495694945,0.8699617484669014,0.5984251968503937,0.9631366500844956,1.0,4/18,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,microtubule binding (GO:0008017),-0.19545017617738797,-0.8695947226268208,0.8419540229885057,0.8640910223075972,1.0,77/222,27.46%,MTUS1;DNM3;DST;STARD9;MACF1;MID1;EML1;MID2;FAM161A;GABARAPL2;ARHGEF2;SGIP1;MAP4;CLIP4;MAP7D3;MAP1LC3B;APC;RPS3;CDK5;MAP4K4;NEFM;WHAMM;MAP9;FGF13;MACO1;DYNC1I1;CLIP2;KIF23;RMDN1;HDAC6;TRPV4;GAS2L1;REEP3;CLIP1;VAPB;KATNB1;KIF1C;MAP1B;FMR1;PAFAH1B1;MAST2;TOGARAM1;NUSAP1;PEX14;CEP295;GAPDH;CRIPT;KIF20B;RAB11A;CCDC69;KIF13A;REEP1;RP1;MAPRE2;PRC1;DCTN1;TPX2;KNSTRN;FSD1;KIFC1;MAP6D1;CDK5RAP2;POLB;STIM1;SYBU;NDEL1;KIF22;REEP2;VAPA;KIF14;KATNA1;MAPRE3;CCSAP;CCDC170;CAMSAP2;FBXW11;DNM1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.2890658120025074,-0.8663828989586694,0.6495901639344263,0.8671532592669311,1.0,6/22,21.60%,CACNA1G;SCN4B;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3539897947767816,-0.8653939016676482,0.6351084812623274,0.8657633058401722,1.0,7/11,55.10%,SLC25A47;SLC25A45;SLC22A4;SLC22A3;SLC22A1;SLC25A48;SLC25A29
prerank,SUMO transferase activity (GO:0019789),0.33685644247821994,0.8652562534561213,0.6413255360623782,0.9699797323733116,1.0,4/16,16.71%,TOPORS;PIAS4;HDAC4;MDM2
prerank,RNA polymerase II complex binding (GO:0000993),0.28767844200632564,0.8645758670909649,0.6636029411764706,0.9677870095175309,1.0,7/32,13.15%,CTR9;CCAR2;HNRNPU;CDC73;SCAF1;RPRD2;SMYD2
prerank,MAP kinase phosphatase activity (GO:0033549),0.3590904223388123,0.8642069900283054,0.6338028169014085,0.964815544619211,1.0,1/12,1.62%,DUSP29
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.30440497406815814,-0.8628874713635554,0.6565874730021598,0.867535901883802,1.0,7/18,20.35%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3;AGAP2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3471347571745822,-0.8615357543904532,0.6719681908548708,0.8671792683729916,1.0,5/12,22.29%,CISD2;XDH;AOX1;ISCA2;FXN
prerank,adenylate cyclase binding (GO:0008179),0.37968433205098495,0.8614014239418236,0.6368932038834951,0.9673286292383593,1.0,1/10,0.47%,ADCY5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3300181739374998,-0.8613284551636637,0.6499032882011605,0.8642161812122724,1.0,8/15,33.62%,SCARB1;ZFYVE16;SNX10;EPB41;WDFY3;ZFYVE9;SESTD1;SCIN
prerank,gap junction channel activity (GO:0005243),0.30555251561919294,0.8610745894422229,0.6679174484052532,0.9643667589449838,1.0,3/22,12.96%,GJB6;GJB2;GJA3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.30228927652097887,0.8609604646693109,0.6527514231499051,0.9609136948191142,1.0,8/24,17.45%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,cation:chloride symporter activity (GO:0015377),0.3662930301896668,0.8607069700642515,0.6257545271629779,0.957751169265437,1.0,3/10,11.41%,SLC6A1;SLC12A5;SLC12A1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.356283744527674,-0.858989703715915,0.6502057613168725,0.8655331002199768,1.0,7/11,36.66%,KCNMB2;KCNU1;KCNN3;KCNN1;KCNMB4;KCNMA1;KCNMB1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3410860057985521,-0.8572474826777843,0.6854838709677419,0.8656237666937214,1.0,8/12,35.91%,GNS;ARSA;SGSH;ARSJ;IDS;SULF1;ARSI;SULF2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3416186250642028,-0.8541414558627467,0.6500994035785288,0.8685624937885892,1.0,5/12,31.02%,CNOT6L;PAN3;TOE1;CNOT1;NOCT
prerank,wide pore channel activity (GO:0022829),0.30013571232469455,0.8538989894469701,0.6836158192090396,0.9692776846909519,1.0,3/23,12.96%,GJB6;GJB2;GJA3
prerank,mRNA binding (GO:0003729),0.20100804970743053,0.8530884522504172,0.8636363636363636,0.967359124852917,1.0,54/249,20.35%,CPEB2;CELF2;DDX5;SRRM2;NOVA1;SRSF5;ANGEL2;CPSF6;ELAVL4;ACO1;HNRNPA2B1;PABPC4L;RBM47;HNRNPU;PTBP2;NCBP3;UNK;CPEB4;HNRNPL;PTBP1;UTP23;ELAVL1;SRRM4;C1QBP;RNF20;YTHDC1;FUBP1;SLBP;NUP98;BOLL;UPF3B;PURB;FXR2;RBM5;CSDC2;ETF1;GRSF1;PCBP4;SNIP1;ELAVL2;CCT5;RNPS1;RBPMS2;PTBP3;SRSF6;CELF6;CPEB3;RBFOX1;LARP4B;PUM3;SF3B1;EIF2A;DDX3X;EIF3A
prerank,ribosome binding (GO:0043022),-0.24745803220152796,-0.8528237609413548,0.7073170731707317,0.8678039089658287,1.0,13/46,16.86%,NAA16;SERBP1;RACK1;EEF2;SRP19;MTIF3;TMCO1;GTPBP6;SEC61A1;NOMO1;FMR1;NCLN;NAA10
prerank,potassium ion antiporter activity (GO:0022821),0.33441912404311736,0.8512635847244173,0.6288461538461538,0.9677792427667048,1.0,3/15,15.53%,SLC24A3;SLC9A9;SLC9A3
prerank,sodium channel regulator activity (GO:0017080),-0.2536287232159403,-0.8509078471724612,0.7044444444444444,0.8682687852490776,1.0,6/37,13.84%,NEDD4L;FXYD5;CAMK2D;FXYD6;FGF13;SCN4B
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.34184603890178045,0.8469520536206974,0.668724279835391,0.9734776068870098,1.0,2/15,10.02%,KMT2A;SETD4
prerank,solute:anion antiporter activity (GO:0140323),-0.33316116247828176,-0.8469273951158651,0.6625514403292181,0.872531501540815,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,RNA cap binding (GO:0000339),0.3272898809990603,0.8468029537716527,0.6230769230769231,0.9700724279688046,1.0,7/16,21.40%,CYFIP2;NCBP3;CYFIP1;EIF4E2;SNUPN;LARP1;DCPS
prerank,phospholipase inhibitor activity (GO:0004859),0.3700767283094633,0.8460476120240247,0.6365461847389559,0.9680192839094288,1.0,1/10,2.90%,ANXA5
prerank,kinase inhibitor activity (GO:0019210),-0.26107290523549664,-0.8455946124423122,0.7253218884120172,0.8716702890576804,1.0,11/33,23.95%,LRP6;YWHAB;NCK1;CDKN1C;PARVA;GSKIP;TAOK3;SOCS3;PRKRIP1;CDKN1B;SOCS1
prerank,phospholipase activator activity (GO:0016004),0.37806940950785617,0.8451775415199329,0.6352459016393442,0.966327761203838,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.23063834682196976,-0.8438296195988961,0.778021978021978,0.8717127393221672,1.0,22/57,29.48%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15;UQCR10;NDUFA4L2;CYBRD1;UQCRC1;NDUFB8;COX4I2;CYB561D2;NDUFA9
prerank,O-acyltransferase activity (GO:0008374),0.28630820004904056,0.8426409744737837,0.6845878136200717,0.9678228270860969,1.0,6/30,12.75%,SOAT2;PLA2G4C;SOAT1;MOGAT1;PLA2G15;DGAT2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3517074804165254,0.8416324351454905,0.6685934489402697,0.966381120716071,1.0,6/11,22.88%,CASP3;CFLAR;CASP12;PYCARD;CASP9;CASP6
prerank,miRNA binding (GO:0035198),-0.26676820620124003,-0.8400270644545802,0.7266514806378133,0.8756241418241488,1.0,9/30,19.09%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A
prerank,5'-3' exonuclease activity (GO:0008409),0.3340515473319431,0.8398629127115982,0.6857142857142857,0.9664259024301883,1.0,3/14,16.96%,CPSF3;MRE11;EXOG
prerank,chemoattractant activity (GO:0042056),-0.2788090919938131,-0.8389320511142998,0.7339055793991416,0.8742168635304235,1.0,5/26,13.82%,VEGFC;BMP4;FGF2;FGF7;VEGFA
prerank,glucose transmembrane transporter activity (GO:0005355),0.32485840055079496,0.8385943172661168,0.6705426356589147,0.9654107495593376,1.0,2/17,2.69%,SLC5A3;SLC5A10
prerank,hexosaminidase activity (GO:0015929),0.3532463445997865,0.8348356755855383,0.6836734693877551,0.969758212370841,1.0,4/12,13.36%,NAGA;HEXD;SPAM1;HYAL1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.34634610499391005,0.8345467698005069,0.6773547094188377,0.9668457758781851,1.0,5/13,30.04%,DICER1;SLX4;DNASE1L2;DNASE1L1;ENDOV
prerank,endopeptidase activity (GO:0004175),-0.18041282111949408,-0.8334915669657469,0.9355742296918768,0.8807700487565059,1.0,47/257,18.93%,ADAMTSL3;ECE1;ADAMTSL1;HTRA3;PCSK5;FAP;F3;USP24;ADAMTS5;ADAMTS17;PIK3IP1;ADAMTS6;ADAM10;PSMA6;ADAMTS1;PSMB7;USP46;CASP7;ADAM19;ADAMTS14;USP7;DDI2;CTSO;USP35;PSMB6;MMP11;MALT1;CTSB;PSMB5;ADAMTS20;ACE2;USP47;TPP2;PSMB8;ADAMTS2;ADAM33;TYSND1;RHBDD1;CTSF;PHEX;ADAMTS12;CTSS;MMP2;PSMB4;UCHL1;PSEN2;USP10
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3318790478069545,-0.8333564239758942,0.6646942800788954,0.8777035466716144,1.0,3/12,14.21%,SPPL3;DDI2;HM13
prerank,damaged DNA binding (GO:0003684),0.2590575180461262,0.8333022444438765,0.7364620938628159,0.9659272999647794,1.0,4/44,5.75%,DDB2;ERCC1;XRCC1;AUNIP
prerank,cytochrome-c oxidase activity (GO:0004129),0.3267796544021363,0.8325164038627277,0.6818181818181818,0.9640292800101243,1.0,4/15,12.68%,COX7A1;COX7A2L;CYB5A;COX10
prerank,pyrophosphatase activity (GO:0016462),0.25173270307234435,0.8324376630852444,0.725314183123878,0.9606909017623719,1.0,10/50,14.69%,BNIPL;FITM2;ENPP3;PRUNE1;PRUNE2;NUDT4;CILP2;TRPM2;NUDT11;PPA1
prerank,ferrous iron binding (GO:0008198),-0.2896988712055282,-0.8320061910163047,0.754601226993865,0.876992837700538,1.0,9/21,29.62%,FTO;ALKBH1;FTL;ALKBH2;FXN;EGLN3;FECH;FTH1;ACP5
prerank,growth factor activity (GO:0008083),0.2292412911949586,0.8305310389296038,0.764406779661017,0.961318307392673,1.0,12/74,15.61%,FGF1;FGF4;FGF9;NRTN;NRG1;INHA;ENDOU;BDNF;HBEGF;CSPG5;IL6;HGF
prerank,pseudouridine synthase activity (GO:0009982),-0.32768013728589607,-0.8272078303144935,0.7023346303501945,0.8821135432357045,1.0,5/13,29.11%,PUS3;PUS7L;DKC1;PUSL1;RPUSD3
prerank,WW domain binding (GO:0050699),0.28637285253056427,0.8262577734627923,0.7087378640776699,0.966325792433956,1.0,7/26,16.67%,NDFIP1;TNK2;CDC25C;WBP11;PMEPA1;NDFIP2;SCNN1A
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.300860448716123,0.8253693144656659,0.6877394636015326,0.9644288182472857,1.0,8/22,17.80%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2;ATP2A1
prerank,thyroid hormone receptor binding (GO:0046966),0.2829719666491335,0.824434814521252,0.7314285714285714,0.962910908978,1.0,5/28,9.97%,BRD8;HMGN3;PRMT2;MED1;NSD1
prerank,translation elongation factor activity (GO:0003746),0.32228688628164714,0.8226562412595189,0.662109375,0.9629380829159978,1.0,2/14,5.24%,GTPBP1;TUFM
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.33463286438604295,0.8209122112131684,0.6912878787878788,0.9629509731429737,1.0,2/13,4.09%,GABRG1;GLRA1
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3055162297977216,-0.8199598707019113,0.7223340040241448,0.8913615230972537,1.0,5/17,18.32%,DTYMK;NME6;CLP1;NME2;AK4
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.33726919938184696,0.819443203378389,0.6897880539499036,0.962216169820517,1.0,6/12,21.40%,CYFIP2;NCBP3;CYFIP1;EIF4E2;LARP1;DCPS
prerank,chloride channel inhibitor activity (GO:0019869),0.3491628272949757,0.8190180395234579,0.6782273603082851,0.9595944729536693,1.0,2/10,6.71%,WNK3;WNK4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.2737553974359542,-0.8184686109098679,0.7307692307692307,0.8907872354180195,1.0,7/24,19.48%,EEF2K;CAMK2D;MAPKAPK2;PTK2B;PHKA2;MKNK2;CAMK1G
prerank,anion:anion antiporter activity (GO:0015301),0.3143708802791297,0.8162441975770454,0.6952380952380952,0.9616508330857705,1.0,6/17,16.05%,SLC26A1;SLC25A5;SLC25A11;SLC19A1;SLC4A3;SLC26A11
prerank,ribonuclease activity (GO:0004540),0.24033666153868938,0.8154906330242819,0.7777777777777778,0.959646909643225,1.0,11/56,16.96%,RNASEH2A;YBEY;CPSF3;EXOSC8;EXOSC2;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,phospholipase activity (GO:0004620),0.2324412906106047,0.8151042873089713,0.7978533094812165,0.9570652851398169,1.0,15/67,16.09%,ASPG;PLAAT5;PLA2G4C;DDHD2;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3;GDE1;PLBD2;PLCB3;PDIA3;PLAAT3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3405279567807059,-0.8117791042698158,0.7104722792607803,0.8990127403726644,1.0,3/11,17.87%,ALKBH1;RPS3;NEIL3
prerank,motor activity (GO:0003774),-0.22177163191674049,-0.8110905713214487,0.8075221238938053,0.8969332678034057,1.0,19/60,25.85%,MYH9;STARD9;DYNC1I2;MYL6;DYNLRB1;DNAH2;DYNC1I1;KIF23;KIF1C;KIF24;DNAH3;KIF20B;KIF13A;GPR88;MYO1E;KIFC1;KIF22;KIF4A;KIF14
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3162122970679736,-0.810404064604764,0.7345679012345679,0.894857820202451,1.0,3/13,6.98%,SLC38A5;SLC7A7;SLC7A1
prerank,NADPH binding (GO:0070402),-0.3252185483915241,-0.8091096739956698,0.712,0.8937033376984777,1.0,5/13,21.35%,QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,Hsp70 protein binding (GO:0030544),0.2727851718962416,0.8091045316747267,0.7519685039370079,0.964919651494517,1.0,7/31,15.61%,DNAJC18;DNAJB14;PPEF2;DNAJC10;GPR37;TSC1;DNAJB2
prerank,NADP binding (GO:0050661),-0.2557975766200581,-0.8072708566313432,0.7654320987654321,0.8935768335270947,1.0,8/32,21.35%,NOS3;ME1;CAT;QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,poly-purine tract binding (GO:0070717),0.2796383851715864,0.8071602591001603,0.7427536231884058,0.9650559095484212,1.0,5/27,8.35%,ELAVL4;PABPC4L;HNRNPU;PATL1;TIA1
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.31427369779054515,-0.8063522397341223,0.7464503042596349,0.8918671221685731,1.0,4/14,18.32%,DTYMK;NME6;NME2;AK4
prerank,peptide hormone receptor binding (GO:0051428),0.3324605858141133,0.8061029741099881,0.6987951807228916,0.9636261982035084,1.0,3/11,19.82%,VIP;PSMC5;GNRH1
prerank,poly(U) RNA binding (GO:0008266),0.30013764584492436,0.804730038334294,0.7047619047619048,0.9628513829913502,1.0,3/20,6.28%,RBM11;PABPC4L;PATL1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2861189628630188,0.8043879112809352,0.7467166979362101,0.9601841864227033,1.0,5/22,13.57%,OPTN;IKBKG;SPRTN;IKBKE;OTUD7A
prerank,poly(A) binding (GO:0008143),0.29581315207399006,0.8005803502890685,0.7425925925925926,0.9636664808949343,1.0,4/21,8.35%,ELAVL4;PABPC4L;HNRNPU;TIA1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.26114360198795217,0.8004773864920567,0.7610294117647058,0.9605317579032512,1.0,10/33,21.98%,CTR9;CCAR2;HNRNPU;CDC73;RPRD2;SMYD2;RRN3;SUPT4H1;SPTY2D1;WDR43
prerank,actinin binding (GO:0042805),0.29496735803325314,0.8000031757496706,0.7448405253283302,0.9581320495194778,1.0,3/21,8.50%,CACNA1D;CSRP3;CSRP1
prerank,MHC class I protein binding (GO:0042288),0.31753802671928816,0.7989841297161715,0.7203883495145631,0.9566309437337664,1.0,1/13,2.18%,DERL1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.30770337654308555,-0.7975063150702353,0.7409638554216867,0.9031673956789671,1.0,5/14,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.33807326191035314,0.7904734440482225,0.7216699801192843,0.9677308738323284,1.0,1/10,0.63%,DSC2
prerank,ligand-gated anion channel activity (GO:0099095),0.2991098392696416,0.7901668762224698,0.7352380952380952,0.9649946332058782,1.0,5/17,18.56%,GABRG1;GLRA1;GABRG3;GABRB2;GABRB3
prerank,mannosyltransferase activity (GO:0000030),-0.27331410500519027,-0.7866437141844216,0.7765726681127982,0.9170918004658747,1.0,2/21,5.06%,TMTC2;TMTC1
prerank,I-SMAD binding (GO:0070411),-0.3055268901863559,-0.7864914069312641,0.7722772277227723,0.914063081718322,1.0,3/13,5.45%,SMURF1;SMAD5;SMAD1
prerank,methyltransferase activity (GO:0008168),0.2444718518375412,0.7864670211498338,0.7923211169284468,0.96812139801272,1.0,15/46,21.97%,METTL27;ARMT1;N6AMT1;NSUN3;BCDIN3D;TRMT11;COMT;NSUN2;PRMT3;NTMT1;RRP8;COMTD1;COQ3;AS3MT;PRMT5
prerank,aspartic-type peptidase activity (GO:0070001),-0.33673843616629545,-0.7847474786051402,0.734251968503937,0.9135006727578694,1.0,2/10,8.63%,CTSD;DDI2
prerank,chloride channel regulator activity (GO:0017081),0.3130488338242056,0.7837070483610112,0.7367387033398821,0.9695425709199098,1.0,2/14,6.71%,WNK3;WNK4
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3299738215270305,-0.781643435900136,0.757396449704142,0.9150493884370406,1.0,4/10,29.65%,NAA16;NAA10;NAA15;NAA50
prerank,DNA secondary structure binding (GO:0000217),-0.24318241287746528,-0.7811515912469796,0.8298319327731093,0.9124482996058061,1.0,5/31,12.68%,MEF2C;RAD51B;XPC;BLM;LIN54
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.24006617147170084,-0.7808876764845367,0.841991341991342,0.9096771171580197,1.0,7/34,12.38%,STK3;IQGAP1;CAB39;CALM3;SPRY2;IGF2;INCENP
prerank,transferrin receptor binding (GO:1990459),0.3341497204162916,0.7807020490968908,0.7484787018255578,0.9712082276397405,1.0,2/10,6.34%,CHUK;IKBKG
prerank,leucine zipper domain binding (GO:0043522),0.3428563322194006,0.7802028986208326,0.76,0.96873358451489,1.0,1/10,2.44%,PAWR
prerank,protein phosphatase activator activity (GO:0072542),0.31476770542230925,0.7801050604841409,0.7637051039697542,0.9656986931276016,1.0,2/13,7.65%,IGFBP3;PHACTR4
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3010840585771193,-0.7797256078806007,0.7949260042283298,0.9082917371433431,1.0,4/14,16.72%,TSEN2;ELAC2;RPP21;RPP38
prerank,tubulin binding (GO:0015631),0.1815751120921765,0.7787918479689228,0.96274217585693,0.9646303195319567,1.0,33/296,10.61%,GJB6;FMN1;MTUS2;MAP2;EML4;KIF5C;TTLL6;CLIP3;IFT74;IRAG2;EML2;PLK1;PRUNE1;CLASP1;DNAL1;KIF3C;PDCD5;KIF16B;ABRAXAS1;AGBL4;TBCE;KIF13B;TUBGCP5;LRRK2;GOLGA2;HTT;SKA2;TUBGCP4;NDRG1;DRG1;APC2;SBDS;RITA1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.34308186112636374,0.7775124859590781,0.7545271629778671,0.963455072005959,1.0,3/10,18.78%,NOX1;CYBA;NCF1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.32207291855137843,-0.7757837818229723,0.76,0.9107436843821733,1.0,7/11,43.28%,NAA16;NAA10;NAA15;NAA50;NAA60;NAA40;NAA11
prerank,mRNA methyltransferase activity (GO:0008174),0.3149965278388651,0.7650722724366954,0.7766599597585513,0.979647904286984,1.0,5/12,23.41%,RNMT;NSUN2;TRMT61B;TRMT10C;METTL8
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.27007142597959716,-0.765049744921185,0.8004385964912281,0.9225724347369376,1.0,5/20,16.55%,EIF3H;USP7;EIF3F;USP47;USP50
prerank,alpha-actinin binding (GO:0051393),-0.25398992865006476,-0.7642416382346875,0.8336886993603412,0.9205157772580664,1.0,4/24,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,single-stranded DNA binding (GO:0003697),0.20906428969579605,0.7620954693974967,0.9089376053962901,0.9811053797707594,1.0,22/93,19.37%,ERCC1;PMS2;HNRNPU;MEIOB;SPRTN;SSBP2;TDP2;SSBP1;WBP11;FUBP1;PURB;MSH3;RAD51D;RNF138;POLR3C;RPA3;MCM7;POLR2D;MCMDC2;RAD52;HMCES;LONP1
prerank,NF-kappaB binding (GO:0051059),0.27110339193479926,0.7596419062706318,0.8105646630236795,0.9816186262882004,1.0,5/24,17.40%,CDKN2A;CPNE1;COMMD7;COMMD6;RELA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2237590785644879,0.7561370643542283,0.8695652173913043,0.9834810400917193,1.0,10/54,15.49%,UPB1;ASPG;PM20D1;MIER3;ASPA;GLS2;HINT3;HDAC4;NAAA;SIRT1
prerank,peptidoglycan binding (GO:0042834),0.3234449637627098,0.753313032770487,0.7833333333333333,0.9845308141931703,1.0,3/10,15.83%,PGLYRP3;NLRP3;HK1
prerank,lipid phosphatase activity (GO:0042577),-0.2897614822660115,-0.7527286115951389,0.7635983263598326,0.9329069945924878,1.0,5/14,24.39%,PLPP1;PLPP3;SGPP1;PLPP2;PLPP6
prerank,single-stranded RNA binding (GO:0003727),0.23708460101030251,0.7521484221465443,0.8492201039861352,0.9830458711172798,1.0,15/43,25.36%,RBM11;HNRNPU;PTBP1;ZFR2;SRA1;AGO3;TLR8;POLR2D;LONP1;ILF3;DDX3X;DHX58;SNRPC;JMJD6;U2AF2
prerank,endoribonuclease activity (GO:0004521),0.24879908223460226,0.7518030101478748,0.8568738229755178,0.9804028885821217,1.0,8/32,16.96%,YBEY;CPSF3;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.20872404002051959,0.7506205851999466,0.8795180722891566,0.9788836847387632,1.0,15/75,19.30%,ADH7;ADH4;SORD;ME2;PTGR1;DHRS11;BDH1;SDR42E1;GFUS;LDHD;LDHB;PRXL2B;HSD17B11;HMGCR;HSD17B4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2297310099871887,-0.7489120229333147,0.8918367346938776,0.9346077832165105,1.0,11/34,21.77%,UBE2D3;UBE2J1;UFC1;UBE2F;UBE2L3;UBE2Q1;UBE2J2;UBE2A;UBE2G1;UBE2QL1;UBE2Z
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.22064294449744343,-0.7485615697151394,0.8863109048723898,0.9319104001701454,1.0,7/38,16.64%,SHANK3;PIK3R1;NCK1;SPATA2;SH2B2;IRS1;LDLRAP1
prerank,deubiquitinase activity (GO:0101005),-0.18801342846250957,-0.7446068241112833,0.9404466501240695,0.9338621968361369,1.0,24/88,25.22%,USP53;USP24;EIF3H;USP46;OTUD7B;MINDY1;USP7;USP35;EIF3F;MINDY2;USP47;USP50;JOSD1;PSMD14;UCHL1;USP10;ZC3H12A;UCHL5;USP15;CYLD;ATXN3;OTUB2;USP1;UFD1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.32044534758463566,0.7445613545307151,0.7886497064579256,0.98428761239155,1.0,5/10,22.88%,CASP3;CFLAR;CASP12;CASP9;CASP6
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3088876559449497,0.7443098349358309,0.7649325626204239,0.9814548756345465,1.0,4/12,17.40%,RUVBL2;STAT1;TAF1;RELA
prerank,deoxyribonuclease activity (GO:0004536),0.2939485780773704,0.7434149004494612,0.771255060728745,0.9795573526732428,1.0,9/14,32.22%,MBD4;MRE11;DNASE1L2;APEX1;DNASE1L1;MAP1S;ZRANB3;NME1;ERCC5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3132767013670145,0.7401531478675262,0.7709163346613546,0.9809938947576408,1.0,1/11,4.43%,ARG2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.32119567165215795,0.7394401064277899,0.787321063394683,0.9788070919386002,1.0,2/10,7.91%,B4GALT1;B3GALT6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2931995840648397,0.7368639720860487,0.8148854961832062,0.9789426488202146,1.0,4/15,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32496390684828336,0.7368562691096393,0.7924901185770751,0.9758735172780365,1.0,10/10,67.52%,APEX1;MGME1;TATDN1;DCLRE1A;POLD1;EXD2;EXO1;DCLRE1B;DCLRE1C;FEN1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.20131084612233188,0.7359464363910512,0.9415929203539823,0.9740355995342035,1.0,23/78,23.29%,CAPN3;USP11;CASP3;USP12;USP18;USP26;USP40;CFLAR;CTSH;USP20;PDIA3;USP42;USP9X;USP48;CASP12;CAPN15;USP16;PYCARD;CAPN10;CAPN11;CASP9;CASP6;LGMN
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.31807702464737153,0.7316955715448109,0.8043912175648703,0.9763669250593914,1.0,2/10,4.38%,PIK3R3;PIK3CB
prerank,general transcription initiation factor binding (GO:0140296),-0.24643032388759561,-0.7311530154969729,0.8562628336755647,0.9469287407648984,1.0,5/25,17.42%,ESR1;AR;AHR;HHEX;RUVBL1
prerank,tropomyosin binding (GO:0005523),0.28089203982250943,0.7294908737282774,0.811088295687885,0.97593998185031,1.0,2/16,9.02%,NEBL;TMOD2
prerank,phospholipase binding (GO:0043274),0.30251333521558343,0.7294025733361745,0.7958762886597938,0.9730163159069494,1.0,2/13,6.70%,ARHGAP6;PDPK1
prerank,lysophospholipase activity (GO:0004622),-0.25952802331972036,-0.7283263239034549,0.8611713665943601,0.947083202955097,1.0,4/20,14.39%,PLA2G4A;MGLL;ABHD4;PLA2G6
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3007030397290535,-0.7279112826433719,0.8169556840077071,0.944469087853055,1.0,5/10,31.29%,ANKRD13A;ANKRD13B;ANKRD13D;FAAP20;LAPTM5
prerank,P-type ion transporter activity (GO:0015662),-0.2927071268907784,-0.7278492491665824,0.8199608610567515,0.9413713270790717,1.0,2/12,8.58%,ATP2B1;ATP2A3
prerank,endonuclease activity (GO:0004519),0.22057684366849936,0.7262976366124605,0.8856624319419237,0.9737932454178472,1.0,10/49,16.96%,YBEY;CPSF3;MBD4;MRE11;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,exonuclease activity (GO:0004527),0.22141950238316666,0.7256314706766129,0.8884758364312267,0.9715000188449205,1.0,8/46,16.96%,ENPP3;CPSF3;EXOSC8;MRE11;EXOSC2;AEN;POLG;EXOG
prerank,regulatory RNA binding (GO:0061980),-0.216750197170236,-0.722681079253108,0.9061784897025171,0.9439486479460215,1.0,12/38,25.43%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A;PIWIL2;TARBP2;MATR3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.26801248956720225,-0.7221354600842526,0.8651452282157677,0.9413914428709406,1.0,5/16,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,CXCR chemokine receptor binding (GO:0045236),-0.2909268752202278,-0.7217109992885267,0.8373493975903614,0.9388107234922181,1.0,7/11,48.72%,CXCL12;CXCL5;CXCL1;PF4;PPBP;CXCL13;CXCL2
prerank,CCR chemokine receptor binding (GO:0048020),-0.23223048202142493,-0.7200645941654944,0.8808510638297873,0.937464970805786,1.0,19/28,48.65%,CCL13;CCL25;CCR2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL19;CCL14;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,carboxy-lyase activity (GO:0016831),0.2581709172767629,0.7200603913935544,0.8409961685823755,0.975014119143243,1.0,7/23,23.25%,GGCX;GAD1;AZIN2;UMPS;FAHD1;PISD;BCKDHA
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2287916168378233,0.7138952663567975,0.9045871559633027,0.9792932584846895,1.0,11/37,19.42%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;IARS2;FARSA;IARS1;YARS1
prerank,kinesin binding (GO:0019894),-0.2248835630504932,-0.7090577867403147,0.8928571428571429,0.9457685354351322,1.0,5/27,19.70%,ACTB;AP1AR;ATCAY;ARHGEF10;PRC1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19492992096336767,0.7061406653671798,0.9446366782006921,0.9847858530039731,1.0,19/83,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,nucleotidyltransferase activity (GO:0016779),0.2582048466712338,0.7060435189610883,0.8656126482213439,0.9819067412109833,1.0,5/19,14.82%,TENT4A;REV1;TUT4;TERT;CRPPA
prerank,5'-nucleotidase activity (GO:0008253),-0.2735203547645831,-0.6960911563868758,0.8394004282655246,0.9552005975294722,1.0,4/13,22.13%,NT5C1A;NT5E;NT5C;ACP3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.2916509730069051,0.6908706240503113,0.8508604206500956,0.9947535495054985,1.0,11/11,70.86%,CNGB1;HCN1;CNGA1;KCNA10;HCN2;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,pyridoxal phosphate binding (GO:0030170),-0.23500418281841395,-0.6881546967939204,0.8989690721649485,0.9595373571154056,1.0,9/20,28.59%,SRR;PYGB;THNSL2;PDXK;PNPO;SHMT2;AGXT;CBS;SHMT1
prerank,omega peptidase activity (GO:0008242),0.1870694584466198,0.6881265629925485,0.9648829431438127,0.9945545053554019,1.0,20/89,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;GGT5;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,endopeptidase activator activity (GO:0061133),-0.28959103245035767,-0.6873590240125257,0.8611111111111112,0.9571154829479426,1.0,4/10,21.47%,ADRM1;PSMD14;PSENEN;PSME1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2689102345796094,-0.6864336249020137,0.8405797101449275,0.9548781712052575,1.0,6/14,21.80%,QDPR;ALDH1L2;DHFR;NOXRED1;BLVRB;PYCR3
prerank,tRNA binding (GO:0000049),0.20618762692999498,0.6797516889739353,0.9314079422382672,0.9997886134932013,1.0,11/43,21.52%,TRMT9B;PSTK;NEMF;DARS2;NSUN2;TERT;NSUN6;ELP5;TRMT10C;EIF2A;DALRD3
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2137515057490988,-0.6766051032228161,0.9434782608695652,0.9604371613986155,1.0,8/29,24.76%,ACER2;GAA;PARG;ACER3;ENGASE;HPSE;PGGHG;GANAB
prerank,cysteine-type peptidase activity (GO:0008234),0.18681431603658913,0.6761971793641502,0.9770723104056437,1.0,1.0,17/73,19.12%,CAPN3;USP11;CASP3;USP12;USP18;USP26;ATG4D;USP40;CTSH;USP20;ATG4C;PDIA3;USP42;USP9X;USP48;USP21;USP16
prerank,calcium channel inhibitor activity (GO:0019855),-0.27810475184831396,-0.6751331742718296,0.8741721854304636,0.9584896441793789,1.0,2/11,9.50%,SLC30A1;MCUB
prerank,four-way junction DNA binding (GO:0000400),0.25547781312576856,0.6733125946341741,0.8893203883495145,0.9997844437361997,1.0,6/17,21.15%,MSH6;MEN1;RAD51D;ABL1;XRCC2;RAD51C
prerank,adenylyltransferase activity (GO:0070566),0.2406383580588366,0.6623601870582448,0.9022988505747126,1.0,1.0,5/21,15.25%,OAS2;TENT4A;OAS3;PAPOLB;ABL1
prerank,aminopeptidase activity (GO:0004177),-0.21730763714824888,-0.6604630414208262,0.9266666666666666,0.9670557288482338,1.0,9/26,26.71%,ENPEP;LAP3;METAP1D;LNPEP;RNPEPL1;ERAP1;KDM8;XPNPEP1;JMJD7
prerank,snRNA binding (GO:0017069),0.20319720494634136,0.6557289478534587,0.9434628975265018,1.0,1.0,14/42,23.83%,CCNT2;HNRNPU;LSM4;LSM11;LSM8;HEXIM2;SNU13;DDX39B;SNRPB2;LARP7;SART3;SF3B3;EFTUD2;SNRPC
prerank,disordered domain specific binding (GO:0097718),0.22946688374813615,0.6496737186735008,0.9312267657992565,1.0,1.0,1/23,0.70%,HSPA1A
prerank,RNA stem-loop binding (GO:0035613),0.2689707384919041,0.6470938449744912,0.8898128898128899,1.0,1.0,5/12,24.95%,EPRS1;CPEB3;DDX3X;CSDE1;MYH10
prerank,exopeptidase activity (GO:0008238),0.19199418358394085,0.6469374491742199,0.9559322033898305,1.0,1.0,8/50,15.33%,METAP2;CTSA;DPP8;CPA2;DPP10;CTSH;CNDP2;TRHDE
prerank,phosphatidate phosphatase activity (GO:0008195),0.26487158127188537,0.6446907459856267,0.8962075848303394,1.0,1.0,2/13,8.88%,LPIN1;PLPPR3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.24876575224151476,-0.6440223150208838,0.9107883817427386,0.9756941367684966,1.0,6/13,32.06%,KCNQ1;PRKAR2B;PRKAR1B;PKIA;PRKAR2A;CSK
prerank,3'-5' exonuclease activity (GO:0008408),-0.18354709226742144,-0.6404724896446924,0.9726027397260274,0.974999493438338,1.0,16/45,31.86%,CNOT6L;REV3L;REXO4;TRIR;TOE1;ERI2;EXD1;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;DIS3L2;NOCT;ISG20;APLF
prerank,exoribonuclease activity (GO:0004532),-0.25731965858788575,-0.6397335082772142,0.9342629482071713,0.9723454201386358,1.0,5/12,26.87%,EXOSC1;ZC3H12A;EXOSC4;EXOSC5;EXOSC3
prerank,MHC protein binding (GO:0042287),-0.22342671965810304,-0.6387668076008194,0.9563409563409564,0.9699250454060241,1.0,3/20,11.83%,TAP2;ATP5F1B;CD74
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.21375544615329395,-0.6366225887400322,0.9481327800829875,0.9682715688786709,1.0,12/24,39.32%,DTYMK;NME6;NME2;AK4;PPIP5K1;PMVK;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3;NME4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22799665972827765,0.6319570580332202,0.9201596806387226,1.0,1.0,3/22,13.69%,DUSP29;MTMR2;DUSP19
prerank,phosphate ion binding (GO:0042301),-0.26730934189377337,-0.6315251128844145,0.9016393442622951,0.9683133466717115,1.0,4/10,31.14%,PDE2A;ADSS1;ADSS2;CHST14
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2520876508830102,0.6314456683150372,0.8980392156862745,1.0,1.0,4/15,16.00%,PIK3R3;PIK3CB;PI4KA;ATM
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.2315436619027179,-0.6295371496853829,0.9445628997867804,0.9665247465089196,1.0,4/16,20.44%,SLC44A2;SLC44A1;SLC7A8;SLC5A7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2699805777505707,0.6294098371919536,0.8906560636182903,1.0,1.0,6/11,28.35%,NUDT4;NUDT11;DCPS;DCP2;NUDT3;NUDT5
prerank,microtubule motor activity (GO:0003777),0.18315159824302246,0.6204032740711843,0.974169741697417,1.0,1.0,10/51,18.89%,DNAH1;KIF5C;KIF3C;KIF16B;KIF13B;KIF3A;SMC3;KIF1B;KIF3B;KIF1A
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.2596927925435329,-0.6186646889802875,0.9244532803180915,0.9699041658156461,1.0,5/10,40.29%,BRCA2;MSL3;NAA50;NAA60;NAA40
prerank,MAP-kinase scaffold activity (GO:0005078),-0.2612763520429521,-0.6181954678115675,0.9366053169734151,0.9671185146280594,1.0,1/11,2.65%,IQGAP1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21288164049404296,0.617720333891751,0.9690346083788707,1.0,1.0,4/28,13.90%,RNASEH2A;POP4;AGO3;DICER1
prerank,mannose binding (GO:0005537),-0.2435327578357995,-0.613824058346064,0.935546875,0.9662680076640368,1.0,1/12,4.00%,LMAN2L
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.19002483520494695,0.611380391661362,0.9787644787644788,1.0,1.0,3/42,7.58%,CDKN2A;CCNT2;CCNYL1
prerank,O-methyltransferase activity (GO:0008171),0.2654778612481072,0.6090992408450537,0.927734375,1.0,1.0,3/10,19.74%,BCDIN3D;COMT;COQ3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.1979390700055974,0.6067125915497289,0.966131907308378,1.0,1.0,9/33,23.21%,ANGEL2;EXOSC2;ANGEL1;USB1;DIS3L;CNOT8;PNLDC1;DCP2;PAN2
prerank,TBP-class protein binding (GO:0017025),-0.21389829484645367,-0.6042785902683045,0.9467213114754098,0.9678599768520934,1.0,4/21,17.42%,ESR1;AHR;HHEX;RUVBL1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.21614375718622467,0.6008360798138258,0.9518716577540107,1.0,1.0,6/21,16.67%,WASF1;RYR2;WASF3;AKAP8;AKAP6;AKAP8L
prerank,RNA methyltransferase activity (GO:0008173),0.2239687914848024,0.6007581365025376,0.941398865784499,1.0,1.0,2/19,8.95%,TRMT9B;BCDIN3D
prerank,CoA hydrolase activity (GO:0016289),0.23035401853155252,0.5989689819640319,0.9390243902439024,1.0,1.0,5/16,22.41%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.253854919494635,-0.5927839001329906,0.947261663286004,0.9699406010080088,1.0,4/10,25.59%,CDA;GDA;ADA;DCTD
prerank,neuropeptide hormone activity (GO:0005184),0.21332998303913547,0.5913620800925388,0.9367816091954023,1.0,1.0,22/22,78.70%,VIP;GRP;PENK;PPY;HCRT;OXT;CORT;QRFP;GHRH;NPPA;ADCYAP1;UCN;CALCB;GAL;SPX;CRH;NMB;PNOC;NPFF;NPY;CCK;AGRP
prerank,water transmembrane transporter activity (GO:0005372),-0.24404880769718118,-0.5898055217674774,0.9521829521829522,0.9680984029493142,1.0,1/11,5.70%,AQP11
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.1786477265583546,-0.5789082522297607,0.991130820399113,0.9695414121395332,1.0,13/34,31.80%,CNOT6L;PAN3;TOE1;ERI2;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;CNOT1;DIS3L2;NOCT;ISG20
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.20005459972134823,0.5777846566719331,0.9746588693957114,1.0,1.0,8/25,24.24%,TNKS2;PARP14;PARP4;PARP16;SIRT1;ART4;PARP10;TIPARP
prerank,ribonuclease P RNA binding (GO:0033204),0.2484902963190158,0.5769135237914628,0.948076923076923,1.0,1.0,1/10,5.55%,POP4
prerank,nuclear localization sequence binding (GO:0008139),0.21865800898654486,0.5747301779243462,0.9633204633204633,1.0,1.0,4/18,16.46%,POM121;BRAP;TNPO2;IPO4
prerank,vitamin D receptor binding (GO:0042809),0.2327275775414973,0.5734230040704057,0.9452054794520548,1.0,1.0,2/14,9.58%,MED1;RXRA
prerank,U6 snRNA binding (GO:0017070),0.23153137550604005,0.5726583332019621,0.9465648854961832,0.9978060993648938,1.0,6/14,26.06%,LSM4;LSM8;DDX39B;LARP7;SART3;PRPF8
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.23588950077676604,0.5644838942398209,0.931640625,0.9983401403387632,1.0,1/11,8.71%,CHRNB2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.18501660709105489,0.562669922610002,0.9743589743589743,0.996179609776293,1.0,1/31,0.58%,UBE2E2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.20844837798527854,0.5550387116619364,0.9761904761904762,0.9960173975908334,1.0,5/17,22.41%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,gamma-tubulin binding (GO:0043015),0.19664789265539534,0.5532571797416028,0.9699812382739212,0.9938177894589741,1.0,4/22,14.01%,TUBGCP5;TUBGCP4;NDRG1;RAD51D
prerank,ribonuclease P activity (GO:0004526),0.2291614769525826,0.545525788420159,0.9674329501915708,0.9936384298759121,1.0,1/11,5.55%,POP4
prerank,nuclear import signal receptor activity (GO:0061608),0.20397466338329895,0.529596537571445,0.9882121807465619,0.9956042509965769,1.0,4/15,22.18%,TNPO3;TNPO2;IPO4;RANBP6
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.19181343941105217,0.52790796305094,0.9867424242424242,0.9933152793905832,1.0,20/21,59.62%,CHRNB2;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNA2;CHRNA6;DRD4;ANXA9;GRIA1;DRD1;CHRNA1;DRD5;CHRNA4;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5
prerank,3'-5' DNA helicase activity (GO:0043138),0.18974918532777196,0.4923102788222261,0.9906191369606003,0.9983573538912311,1.0,1/16,3.36%,RECQL4
prerank,carbohydrate kinase activity (GO:0019200),0.1860012554927809,0.4434595285383714,0.9937888198757764,1.0,1.0,11/11,81.41%,HK1;KHK;HK2;POMK;NAGK;GALK1;GNE;HK3;FGGY;XYLB;GALK2
prerank,sodium channel activity (GO:0005272),0.14044966973465772,0.4378031041694414,0.9982174688057041,0.9996306011046444,1.0,9/37,24.42%,GRIK5;GRIK2;SHROOM2;SCN8A;SCNN1A;SCN9A;ASIC4;ASIC2;HCN1
prerank,nuclease activity (GO:0004518),0.11936833833496799,0.4020835485610148,1.0,0.9988497962956991,1.0,1/52,1.32%,RNASEH2A
